Title of Invention

A METHOD OF REDUCING TRANSGENE SILENCING AND THE EPSPS ARTIFICIAL POLYNUCLEOTIDE EMPLOYED BY SUCH METHOD

Abstract

The materials and methods disclosed provide for polynucleotide molecules sufficiently divergent from polynucleotides naturally contained in plants, or polynucleotides previously introduced into plants as transgenes to permit trait stacking in plant breeding methods or plant transformation methods. The disclosure also provides for methods and compositions to detect the polynucleotides of the invention in plants.

Full Text

11899.0235.00pc00 (MOBT:235P~) METHODS FOR USING ARTIFICIAL POLYNUCLEOTIDES AND COMPOSITIONS THEREOF TO REDUCE TRANSGENE SILENCING This application claims benefit of U.S. Provisional Application No. 60/396,665, filed July 18,2002. BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to plant genetic engineering. More particularly, to a method for constructing an artificial polynucleotide and methods of use to reduce transgene silencing in plants. The invention also relates to the plant cells containing the artificial polynucleotide in which a plant cell is transformed to express the artificial polynucleotide and the plant regenerated therefrom. Description of the Related Art Heterologous genes may be isolated from a source other than the plant into which it will be transformed or they may be modified or designed to have different or improved qualities. Particularly desirable traits or qualities of interest for plant genetic engineering would include but are not limited to resistance to insects, fungal diseases, and other pests and disease-causing agents, tolerances to herbicides, enhanced stability or shelf-life, yield, environmental stress tolerances, and nutritional enhancements. Traditional molecular biological methods for generating novel genes and proteins generally involved random or directed mutagenesis. An example of random mutagenesis is a recombination technique known as "DNA shuffling" as disclosed in US Patents 5,605,793; 5,811,238; 5,830,721; 5,837,458 and International Applications WO 98/31837, WO 99/65927, the entirety of all of which is incorporated herein by reference. An alternative method of molecular evolution involves a staggered extension process (StEP) for in vitro mutagenesis and recombination of nucleic acid molecule sequences, as disclosed in US Patent 5,965,408, incorporated herein by reference. An example of directed mutagenesis is the introduction of a point mutation at a specific site in a polypeptide. An alternative approach, useful when the heterologous gene is from a non-plant source, is to design an artificial insecticidal gene that uses the most often used codon in maize plant codon usage table (Koziel et al., 1993, Biotechnology 11, 194-200). Fischhoff and Perlak (US Patent No. 5,500,365, incorporated herein by reference) report higher expression of Bacillus thuringiensis (Bt) insecticidal protein compared in crop plants when the polynucleotide sequence was modified to reduce the occurrence of destabilizing sequences. It was necessary to modify the wild type Bt polynucleotide sequence because the wild type full length Bt polynucleotide did not express sufficient levels of insecticidal protein in plants to be agronomically useful. Heterologous genes are cloned into vectors suitable for plant transformation. Transformation and regeneration techniques useful to incorporate heterologous genes into a plant's genome are well known in the art. The gene can then be expressed in the plant cell to exhibit the added characteristic or trait. However, heterologous genes that normally express well as transgenes may experience gene silencing when more than one copy of the same genes are expressed in the same plant. This may occur when a first heterologous gene is too similar to an endogenous gene DNA sequence in the plant. Other examples include when a transgenic plant is subsequently crossed to other transgenic plants having the same or similar transgenes or when the transgenic plant is retransformed with a plant expression cassette that contains the same or similar gene. Similarly, gene silencing may occur if trait stacking employs the same genetic elements used to direct expression of the transgene gene of interest. In order to stack traits, stable transgenic lines should be done with different combinations of genes and genetic elements to avoid gene silencing. N-phosphonomethylglycine, also known as glyphosate, is a well-known herbicide that has activity on a broad spectrum of plant species. Glyphosate is the active ingredient of Roundup® (Monsanto Co.), a safe herbicide having a desirably short half-life in the environment. When applied to a plant surface, glyphosate moves systemically through the plant. Glyphosate is phytotoxic due to its inhibition of the shikimic acid pathway, which provides a precursor for the synthesis of aromatic amino acids. Glyphosate inhibits the enzyme 5- enolpyruvyl-3-phosphoshikimate synthase (EPSPS). Glyphosate tolerance can also be achieved by the expression of EPSPS variants that have lower affinity for glyphosate and therefore retain their catalytic activity in the presence of glyphosate (U.S. Patent No. 5,633,435, herein incorporated by reference). Enzymes that degrade glyphosate in plant tissues (U.S. Patent No. 5,463,175) are also capable of conferring cellular tolerance to glyphosate. Such genes are used for the production of transgenic crops that aire tolerant to glyphosate, thereby allowing glyphosate to be used for effective weed control with minimal concern of crop damage. For example, glyphosate tolerance has been genetically engineered into corn (U.S. Patent No. 5,554,798), wheat (U.S. Patent Application No. 20020062503), soybean (U.S. Patent Application No. 20020157139) and canola (WO 9204449), all of which are incorporated by reference. The transgenes for glyphosate tolerance and the transgenes for tolerance to other herbicides, e.g. bar gene, (Toki et al. Plant Physiol., 100:1503- 1507, 1992; Thompson et al. EMBO J. 6:2519-2523, 1987, phosphinothricin acetyltransferase, BAR gene isolated from Streptomyces; DeBlock et al. EMBO J., 6:2513-2522, 1987, glufosinate herbicide) are also useful as selectable markers or scorable markers and can provide a useful phenotype for selection of plants linked with other agronomically useful traits. What is needed in the art are methods to design genes for expression in plants to improve agronomically useful traits that avoid gene silencing when multiple copies are inserted and recombination with endogenous plant genes. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1. Pileup comparison of the polynucleotide sequences changes of two artificial rice EPSPS versions (OsEPSPS_AT, OsEPSPS_ZM) and a native rice EPSPS (OsEPSPS_Nat) the polypeptide of each modified to be glyphosate resistant. Figure 2. Pileup comparison of the polynucleotide sequences of a native (ZmEPSPS_Nat) and an artificial corn EPSPS (ZniEPSPS_ZM) the polypeptide of each modified to be glyphosate resistant Figure 3. Pileup comparison of the polynucleotide sequences of a soybean native EPSPS (GmEPSPS_Nat) and artificial version (GmEPSPS_GM) the polypeptide of each modified to be glyphosate resistant. Figure 4. Pileup comparison of the polynucleotide sequences of a native BAR gene (BARl_Nat) and two artificial versions with Zea mays (BAR1ZM) and Arabidopsis thaliana (BAR1_AT) codon bias. Figure 5. Pileup comparison of the polynucleotide sequences of CTP2 and CP4EPSPS native (CTP2CP4_Nat) and artificial versions (CTP2CP4_AT, CTP2CP4_ZM, and CTP2CP4_GM). Figure 6. Plasmid map of pMON54949. Figure 7. Plasmid map of pMC)N54950. Figure 8. Plasmid map of pMON30151. Figure 9. Plasmid map of pMON59302. Figure 10. Plasmid map of pMON59307. Figure 11. Plasmid map of pMON42411. Figure 12. Plasmid map of pMC)N58400. Figure 13. Plasmid map of pMON58401. Figure 14. Plasmid map of pMON54964. Figure 15. Plasmid map of pMON25455. Figure 16. Plasmid map of pMON30152. Figure 17. Plasmid map of pMON54992. Figure 18. Plasmid map of pMON54985. Figure 19. Plasmid map of pMON20999. Figure 20. Plasmid map of pMON45313. Figure 21. Plasmid map of pMON59308. Figure 22. Plasmid map of pMON59309. Figure 23. Plasmid map of pMON59313. Figure 24. Plasmid map of pMON59396. Figure 25. Plasmid map of pMON25496. BRIEF DESCRIPTION OF SEQUENCE LISTING SEQ ID NO: 1 OsEPSPS_TIPS A rice EPSPS protein sequence modified to be glyphosate resistant, with chloroplast transit peptide. SEQ ID NO:2 OsEPSPS_Nat Polynucleotide sequence of a rice native EPSPS polynucleotide modified to encode a glyphosate resistant protein. SEQ ID NO:3 OsEPSPS_AT Polynucleotide sequence of an artificial rice EPSPS polynucleotide using the Arabidopsis codon usage table and the methods of the present invention, and further modified to encode a glyphosate resistant protein. SEQ ID NO:4 OsEPSPS_ZM Polynucleotide sequence of an artificial rice EPSPS polynucleotide using the Zea mays codon usage table and the methods of the present invention, and further modified to encode a glyphosate resistant protein. SEQ ID NO:5 GmEPSPSJKS A soybean EPSPS protein sequence modified to be glyphosate resistant, with chloroplast transit peptide. SEQ ID NO:6 GmEPSPS_Nat Polynucleotide sequence of a soybean native EPSPS polynucleotide modified to encode a glyphosate resistant protein. SEQ ID NO:7 GmEPSPS_GM Polynucleotide sequence of an artificial soybean EPSPS polynucleotide using the Glycine max codon usage table and the methods of the present invention, and further modified to encode a glyphosate resistant protein. SEQ ED NO:8 ZmEPSPS_TIPS A corn EPSPS protein sequence modified to be glyphosate resistant, with chloroplast transit peptide. SEQ ID N0:9 ZmEPSPS_Nat Polynucleotide sequence of a com native EPSPS polynucleotide modified to encode a glyphosate resistant protein. SEQ ED NO: 10 ZmEPSPS_ZM Polynucleotide sequence of an artificial corn EPSPS polynucleotide using the Zea mays codon usage table and the methods of the present invention, and further modified to encode a glyphosate resistant protein. SEQ ID NO: 11 CTP2 Protein sequence of the chloroplast transit peptide 2 from Arabidopsis EPSPS gene. SEQ ID NO: 12 CTP2_Nat Polynucleotide sequence of the chloroplast transit peptide from Arabidopsis EPSPS. SEQ ED NO:13 CTP2_AT Polynucleotide sequence of an artificial polynucleotide encoding the CTP2 using the Arabidopsis codon usage table and the methods of the present invention. SEQ ED NO: 14 CTP2_ZM Polynucleotide sequence of an artificial polynucleotide encoding the CTP2 using the Zea mays codon usage table and the methods of the present invention. SEQ ID NO: 15 CP4EPSPS The protein sequence of the glyphosate resistant EPSPS protein from Agrobacterium strain CP4. SEQ ID NO:16 CP4EPSPS_Nat Polynucleotide sequence of the native polynucleotide encoding the CP4EPSPS protein (U.S. Patent No. 5,633,435). SEQ ID NO: 17 CP4EPSPS_AT Polynucleotide sequence of an artificial polynucleotide encoding the CP4EPSPS protein using the Arabidopsis codon usage table and the methods of the present invention. SEQ ID NO: 18 CP4EPSPS_ZM Polynucleotide sequence of an artificial polynucleotide encoding the CP4EPSPS protein using the Zea mays codon usage table and the methods of the present invention. SEQ ID NO: 19 B AR1 The protein sequence of a phosphinothricin acetyltransferase. SEQ ID N0:20 BARl_Nat Polynucleotide sequence of the native polynucleotide isolated from Streptomyces encoding the phosphinothricin acetyltransferase. SEQ ID NO:21 BAR1_AT Polynucleotide sequence of an artificial polynucleotide encoding the phosphinothricin acetyltransferase using the Arabidopsis codon usage table and the methods of the present invention. SEQ ID NO:22 BAR1ZM Polynucleotide sequence of an artificial polynucleotide encoding the phosphinothricin acetyltransferase using the Zea mays codon usage table and the methods of the present invention. SEQ ID NO:23 CP4EPSPS_Syn Polynucleotide sequence of an artificial polynucleotide with dicot codon bias. SEQ ID NO:24 CP4EPSPS_ATjpl DNA primer molecule diagnostic for the CP4EPSPS_AT polynucleotide. SEQ ED NO:25 CP4EPSPS_AT_p2 DNA primer molecule diagnostic for the CP4EPSPS_AT polynucleotide. SEQ ID NO:26 CP4EPSPS_ZM_p 1 DNA primer molecule diagnostic for the CP4EPSPS_ZM polynucleotide. SEQ ID NO:27 CP4EPSPS_ZM_p2 DNA primer molecule diagnostic for the CP4EPSPS_ZM polynucleotide. SEQ ID NO:28 CP4EPSPS_Nat_p 1 DNA primer molecule diagnostic for the CP4EPSPS_Nat polynucleotide. SEQ ID NO:29 CP4EPSPS_Nat_p2 DNA primer molecule diagnostic for the CP4EPSPS_Nat polynucleotide. SEQ ID N0:30 CP4EPSPS_Syn_pl DNA primer molecule diagnostic for the CP4EPSPS_Syn polynucleotide. SEQ ID NO:31 CP4EPSPS_Syn_p2 DNA primer molecule diagnostic for the CP4EPSPS_Syn polynucleotide. SEQ ID NO:32 ZmAdhl primerl Control primer 1 diagnostic for endogenous cornAdhl gene. SEQ ID NO:33 ZmAdhl primer2 Control primer 2 diagnostic for endogenous corn Adhl gene. SEQ ID NO:34 GNAGIAMKS Motif providing glyphosate resistance to a plant EPSPS. SEQ ID NO:35 CTPEPSPSCP4_G Polynucleotide sequence of an artificial M polynucleotide encoding the CP4EPSPS protein using the Glycine max codon usage table. SUMMARY OF THE INVENTION The present invention provides methods and compositions to design an artificial polynucleotide sequence that encodes a protein of interest, wherein the artificial polynucleotide is substantially divergent from a polynucleotide naturally occurring in a plant or a polynucleotide that has been introduced as a transgene Into a plant and the artificial polynucleotide and polynucleotide encode a substantially identical polypeptide. The artificial polynucleotides of the present invention that encodes proteins that provide agronomically useful phenotypes to a transgenic plant containing a DNA construct comprising the artificial polynucleotide. The agronomically useful phenotvpes include, but are not limited to: drought tolerance, increased yield, cold tolerance, disease resistance, insect resistance and ^ herbicide tolerance. Another aspect of the present invention are artificial polynucleotides that encode a herbicide resistant EPSPS protein, a phosphinothricin acetyltransferase protein, a chloroplast transit peptide protein. In preferred embodiments of the present invention, the artificial polynucleotide molecule is selected from the group consisting of SEQ ID NO:3, SEQ ID NO:4, SEQ ID N0:6, SEQ ED N0:7, SEQ ID NO: 10, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 17, j £ SEQ ID NO: 18, SEQ ID NO:21, SEQ ID NO:22, and SEQ ID NO:35. j The present invention provides DNA constructs comprising: a promoter molecule that functions in plants, operably linked to an artificial polynucleotide molecule of the present invention, wherein the artificial polynucleotide molecule is selected from the group consisting of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, SEQ ID N0:10, SEQ ID NO:13, SEQ ID NO: 14, SEQ ID NO:17, SEQ ED NO:18, SEQ ID NO:21, SEQ ID NO:22, and SEQ ID NO:35, operably linked to a transcription termination region. The present invention further provides DNA constructs comprising: a promoter molecule that functions in plants, operably linked to an artificial polynucleotide molecule that encodes a j i chloroplast transit peptide, operably linked to a heterologous glyphosate resistant EPSPS, ! operably linked to a transcription termination signal region, wherein the artificial polynucleotide is substantially divergent in polynucleotide sequence from known polynucleotides encoding an identical chloroplast transit peptide. The present invention provides DNA constructs comprising at least two expression cassettes, the first expression cassette comprising a promoter molecule that functions in plants, operably linked to an artificial polynucleotide molecule of the present invention, operably linked to a transcription termination signal region, and the second expression cassette comprising a promoter molecule that functions in plants, operably linked to a polynucleotide molecule that encodes a substantially identical polypeptide as said artificial polynucleotide and is less than eight-five percent similar in polynucleotide sequence to said artificial polynucleotide, operably linked to a transcription termination signal region. The present invention provides plant cells, plants or progeny thereof comprising a DNA construct of the present invention. Of particular interest are plants of progeny thereof selected from the group consisting of wheat, corn, rice, soybean, cotton, potato, canola, turf grass, forest trees, grain sorghum, vegetable crops, ornamental plants, forage crops, and fruit crops. A method of the present invention reduces gene silencing during breeding of transgenic plants comprising the steps of: a) constructing an artificial polynucleotide that is.substantially divergent from known 3 polynucleotides that encode a substantially identical protein, and b) constructing a DNA construct containing said artificial polynucleotide molecule; and | c) transforming said DNA construct into a plant cell; and j d) regenerating said plant cell into a transgenic plant; and e) crossing said transgenic plant with a fertile plant, wherein said fertile plant contains a polynucleotide molecule that encodes a protein substantially identical to a protein encoded by said artificial polynucleotide molecule and wherein said artificial polynucleotide molecule and said polynucleotide molecule are substantially divergent. Another aspect of the invention is a transgenic plant cell comprising two polynucleotides, wherein at least one of the polynucleotides is a transgene and the two polynucleotides encode a substantially identical protein and are less than eight-five percent similar in polynucleotide sequence. Another aspect of the present invention in a method to reduce gene silencing during ——_„ — ~ —* ^roduction of,t:ansgei]ic plants comprises the steps of: a) constructing an artificial polynucleotide that is substantially divergent from known polynucleotides that encode a substantially identical protein, and b) constructing a first DNA construct containing said artificial polynucleotide molecule; and c) transforming said DNA construct into a plant cell; and d) regenerating said plant cell into a transgenic plant; and e) retransforming a cell from said transgenic plant with a second DNA construct comprising a polynucleotide molecule that encodes a substantially identical protein to said artificial polynucleotide and said polynucleotide and artificial polynucleotide are substantially divergent in polynucleotide sequence; and f) regenerating said cell of step d into a transgenic plant comprising both said artificial polynucleotide and said polynucleotide. Further provided by the present invention are methods for selection of a plants transformed with a DNA construct of the invention comprising the steps of: a) transforming a plant cell with a DNA construct of the present invention; and b) culturing said plant cell in a selective medium containing a herbicide selected from the group consisting of: glyphosate and glufosinate, to selectively kill cells which have not been transformed with said DNA constructs; and c) regenerating said plant cell into a fertile plant. Another aspect of the invention is a method of detecting an artificial polynucleotide in a j , , —p. transgenic plant cell, plant or progeny thereof comprising the steps: a) contacting a DNA sample isolated from said plant cell, plant or progeny thereof with a DNA molecule, wherein said DNA molecule comprises at least one DNA molecule of a pair of DNA molecules that when used in a nucleic-acid amplification reaction produces an amplicon ^ that is diagnostic for said artificial polynucleotide molecule selected from the group consisting of: SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO: 10, SEQ ID NO: 13, SEQ ID NO:14, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:21, SEQ ID NO:22, and SEQ IDNO:35. j (a) performing a nucleic acid amplification reaction, thereby producing the amplicon; and (b) detecting the amplicon. Reagents provided for performing the detection method above include, but are not j limited to: DNA molecules that specifically hybridize to an artificial polynucleotide molecule j " selected from the group consisting of: SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:6, SEQ ID j NO:7, SEQ ID N0:10, SEQ ED NO:13, SEQ ID NO:14, SEQ ID NO:17, SEQ ED NO:18, SEQ ID NO:21, and SEQ ED NO:22; and isolated DNA molecules selected from the group consisting . j^f of: SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, and SEQ ID NO:27. I The present invention provides plants, and progeny comprising a DNA molecule selected from the group consisting of: SEQ ID NO:3, SEQ ID NO:4, SEQ ED NO:6, SEQ ID NO:7, SEQ ID NO: 10, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:17, SEQ ID NO:18, SEQ ED NO:21 SEQ ID NO:22, SEQ ED NO:24, SEQ ED NO:25, SEQ ED NO:26, and SEQ ID NO:27. The present invention provides pairs of DNA molecules selected from the group comprising: a first DNA molecule and a second DNA molecule, wherein the first DNA molecule ; is SEQ ID NO:24 or its complement and the second DNA molecule is SEQ ED NO:25 or its - complement and the pair of DNA molecules when used in a DNA amplification method produce an amplicon, and a first DNA molecule and a second DNA molecule, wherein the first DNA j molecule is SEQ ID NO:26 or its complement and the second DNA molecule is SEQ ID NO:27 ' or its complement and the pair of DNA molecules when used in a DNA amplification method produce an amplicon, wherein the amplicon is diagnostic for the presence of an artificial ; polynucleotide of the present invention in the genome of a transgenic plant. The present invention provides for a plant and progeny thereof identified by a DNA amplification method to contain in its genome a DNA molecule selected from the group consisting of: SEQ ED NO:3, SEQ ED NO:4, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO: 10, SEQ ID NO: 13, SEQ ID NO:14, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:21 SEQ ID NO:22, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, and SEQ ID NO:27. The present invention provides and contemplates DNA detection kits comprising: at least ' one DNA molecule of sufficient length to be specifically homologous or complementary to an I artificial polynucleotide selected from the group consisting of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, SEQ ID N0:10, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:17, SEQ ED NO: 18, SEQ ID NO:21, and SEQ ID NO:22, wherein said DNA molecule is useful as a DNA piobe or DNAjjrjmer; or at least one DNA molecule homologous or complementary to a DNA primer molecule selected from the group consisting of: SEQ ID NO:24, SEQ ID NO:25, ' SEQ ID NO:26, and SEQ ID NO:27. The present invention further provides a method of detecting the presence of an artificial polynucleotide encoding a glyphosate resistant EPSPS in a DNA sample, the method comprising: (a) extracting a DNA sample from a plant; and Q (b) contacting the DNA sample with a labeled DNA molecule of sufficient length to be i specifically homologous or complementary to an artificial polynucleotide selected from the group consisting of: SEQ ED NO:3, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, SEQ ID N0:10, SEQ ID NO:13, SEQ ED NO:14, SEQ ID NO:17, and SEQ ID NO: 18, wherein said labeled DNA molecule is a DNA probe; and (c) subjecting the sample and DNA probe to stringent hybridization conditions; and (d) detecting the DNA probe hybridized to the DNA sample. The present invention provides for an isolated polynucleotide that encodes an EPSPS ^ enzyme, the EPSPS enzyme contains the motif of SEQ ID NO:34. The present invention provides for a DNA construct containing a polynucleotide that encodes for the EPSPS enzyme with the motif of SEQ ED NO:34. A plant cell, plant or progeny thereof that is tolerant to glyphosate as a result of expressing an EPSPS enzyme that contains the motif of SEQ ED NO:34 is an aspect of the invention. DETAILED DESCRIPTION OF THE INVENTION The following definitions are provided to better define the present invention and to guide those of ordinary skill in the art in the practice of the present invention. Unless otherwise noted, terms are to be understood according to conventional usage by those of ordinary skill in the relevant art. Definitions of common terms in molecular biology may also be found in Rieger et al., Glossary of Genetics: Classical and Molecular, 5th edition, Springer-Verlag: New York, (1991); and Lewin, Genes V, Oxford University Press: New York, (1994). The nomenclature for DNA bases as set forth at 37 CFR § 1.822 is used. The standard one- and three-letter nomenclature for amino acid residues is used. "Amino-acid substitutions", "Amino-acid variants", are preferably substitutions of single amino-acid residue for another amino-acid residue at any position within the protein. Substitutions, deletions, insertions or any combination thereof can be combined to arrive at a final construct. An "artificial polynucleotide" as used in the present invention is a DNA sequence designed according to the methods of the present invention and created as an isolated DNA molecule for use in a DNA construct that provides expression of a protein in host cells, and for the purposes of cloning into appropriate constructs or other uses known to those skilled in the art Computer programs are available for these purposes, including but not limited to the "BestFit" or "Gap" programs of the Sequence Analysis Software Package, Genetics Computer Group (GCG), Inc., University of Wisconsin Biotechnology Center, Madison, WT 53711. The artificial polynucleotide may be created by a one or more methods known in the art, that include, but are not limited to: overlapping PCR. An artificial polynucleotide of the present invention is substantially divergent from other polynucleotides that code for the identical or nearly identical protein. The term "chimeric" refers to a fusion nucleic acid or protein sequence. A chimeric nucleic acid coding sequence is comprised of two or more sequences joined in-frame that encode a chimeric protein. A chimeric gene refers to the multiple genetic elements derived from heterologous sources comprising a gene. The phrases "coding sequence", "open reading frame", and "structural sequence" refer to the region of continuous sequential nucleic acid triplets encoding a protein, polypeptide, or peptide sequence. "Codon" refers to a sequence of three nucleotides that specify a particular amino acid. "Codon usage" or "codon bias" refers to the frequency of use of codons encoding amino acids in the coding sequences of organisms. "Complementarity" and "complement" when referring to nucleic acid sequences, refers to the specific binding of adenine to thymine (uracil in RNA) and cytosine to guanine on opposite strands of DNA or RNA. "Construct"' refers to the heterologous genetic elements operably linked to each other making up a recombinant DNA molecule and may comprise elements that provide expression of a DNA polynucleotide molecule in a host cell and elements that provide maintenance of the construct. "C-terminal region" refers to the region of a peptide, polypeptide, or protein chain from the middle thereof to the end that carries the amino acid having a free carboxyl group. The term "divergent", as used herein, refers to the comparison of polynucleotide molecules that encode the same or nearly the same protein or polypeptide. The four letter genetic code (A, G, C, and T/U) comprises three letter codons that direct t-RNA molecules to assemble amino acids into a polypeptide from an mRNA template. Having more than one codon that may code for the same amino acid is referred to as degenerate. Degenerate codons are used to construct substantially divergent polynucleotide molecules that encode the same polypeptide where these molecules have a sequence of nucleotides of their entire length in which they are less than 85% identical, and there are no lengths of polynucleotide sequence greater than 23 nucleotides that are identical. The term "encoding DNA" refers to chromosomal DNA, plasmid DNA, cDNA, or artificial DNA polynucleotide that encodes any of the proteins discussed herein. The term "endogenous" refers to materials originating from within an organism or cell. "Endonuclease" refers to an enzyme that hydrolyzes double stranded DNA at internal locations. "Exogenous" refers to materials originating from outside of an organism or cell. This typically applies to nucleic acid molecules used in producing transformed or transgenic host cells and plants. "Exon" refers to the portion of a gene that is actually translated into protein, i.e., a coding sequence. The term "expression" refers to the transcription or translation of a polynucleotide to produce a corresponding gene product, a RNA or protein. "Fragments". A fragment of a gene is a portion of a full-length polynucleic acid molecule that is of at least a minimum length capable of transcription into a RNA, translation into a peptide, or useful as a probe or primer in a DNA detection method. The term "gene" refers to chromosomal DNA, plasmid DNA, cDNA, artificial DNA polynucleotide, or other DNA that encodes a peptide, polypeptide, protein, or RNA molecule, and the genetic elements flanking the coding sequence that are involved in the regulation of expression. The term "genome" as it applies to viruses encompasses all of the nucleic acid sequence contained within the capsid of the virus. The term "genome" as it applies to bacteria encompasses both the chromosome and plasmids within a bacterial host cell. Encoding nucleic acids of the present invention introduced into bacterial host cells can therefore be either chromosomally-integrated or plasmid-localized. The term "genome" as it applies to plant cells encompasses not only chromosomal DNA found within the nucleus, but organelle DNA found within subcellular components of the cell. Nucleic acids of the present invention introduced into plant cells can therefore be either chromosomally-integrated or organelle-localized. "Glyphosate" refers to N-phosphonomethylglycine and its' salts, Glyphosate is the active ingredient of Roundup® herbicide (Monsanto Co.). Plant treatments with "glyphosate" refer to treatments with the Roundup® or Roundup Ultra® herbicide formulation, unless otherwise stated. Glyphosate as N-phosphonomethylglycine and its' salts (not formulated Roundup® herbicide) are components of synthetic culture media used for the selection of bacteria and plant tolerance to glyphosate or used to determine enzyme resistance in in vitro biochemical assays. "Heterologous DNA" sequence refers to a polynucleotide sequence that originates from a foreign source or species or, if from the same source, is modified from its original form. "Homologous DNA" refers to DNA from the same source as that of the recipient cell. "Hybridization" refers to the ability of a strand of nucleic acid to join with a complementary strand via base pairing. Hybridization occurs when complementary sequences in the two nucleic acid strands bind to one another. The nucleic acid probes and primers of the present invention hybridize under stringent conditions to a target DNA sequence. Any conventional nucleic acid hybridization or amplification method can be used to identify the presence of DNA from a transgenic event in a sample. Nucleic acid molecules or fragments thereof are capable of specifically hybridizing to other nucleic acid molecules under certain circumstances. As used herein, two nucleic acid molecules are said to be capable of specifically hybridizing to one another if the two molecules are capable of forming an anti-parallel, double- stranded nucleic acid structure. A nucleic acid molecule is said to be the "complement" of another nucleic acid molecule if they exhibit complete complementarity. As used herein, molecules are said to exhibit "complete complementarity" when every nucleotide of one of the molecules is complementary to a nucleotide of the other. Two molecules are said to be "minimally complementary" if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under at least conventional "low-stringency" conditions. Similarly, the molecules are said to be "complementary" if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under conventional "high-stringency" conditions. Conventional stringency conditions are described by Sambrook et al., 1989, and by Haymes et al., In: Nucleic Acid Hybridization, A Practical Approach, IRL Press, Washington, DC (1985), herein incorporated by reference in its entirety. Departures from complete complementarity are therefore permissible, as long as such departures do not completely preclude the capacity of the molecules to form a double-stranded structure. In order for a nucleic acid molecule to serve as a primer or probe it need only be sufficiently complementary in sequence to be able to form a stable double-stranded structure under the particular solvent and salt concentrations employed. As used herein, a substantially homologous sequence is a nucleic acid sequence that will specifically hybridize to the complement of the nucleic acid sequence to which it is being compared under high stringency conditions. The term "stringent conditions" is functionally defined with regard to the hybridization of a nucleic-acid probe to a target nucleic acid {i.e., to a particular nucleic-acid sequence of interest) by the specific hybridization procedure discussed in Sambrook et al., 1989, at 9.52-9.55. See also, Sambrook et al., 1989 at 9.47-9.52, 9.56-9.58 herein incorporated by reference in its entirety; Kanehisa, (Nucl. Acids Res. 12:203-213, 1984, herein incorporated by reference in its entirety); and Wetmur and Davidson, (J. Mol. BioL 31:349-370, 1988, herein incorporated by reference in its entirety). Accordingly, the nucleotide sequences of the invention may be used for their ability to selectively form duplex molecules with complementaiy stretches of DNA fragments. Depending on the application envisioned, one will desire to employ varying conditions of hybridization to achieve varying degrees of selectivity of probe towards target sequence. For applications requiring high selectivity, one will typically desire to employ relatively stringent conditions to form the hybrids, e.g., one will select relatively low salt and/or high temperature conditions, such as provided by about 0.02 M to about 0.15 M NaCl at temperatures of about 50°C to about 70°C. A stringent conditions, for example, is to wash the hybridization filter at least twice with high-stringency wash buffer (0.2X SSC, 0.1% SDS, 65° C). Appropriate stringency conditions which promote DNA hybridization, for example, 6.0 x sodium chloride/sodium citrate (SSC) at about 45°C, followed by a wash of 2.0 x SSC at 50°C, are known to those skilled in the art or can be found in Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989), 6.3.1-6.3.6. For example, the salt concentration in the wash step can be selected from a low stringency of about 2.0 x SSC at 50°C to a high stringency of about 0.2 x SSC at 50°C. In addition, the temperature in the wash step can be increased from low stringency conditions at room temperature, about 22°C, to high stringency conditions at about 65°C. Both temperature and salt may be varied, or either the temperature or the salt concentration may be held constant while the other variable is changed. Such selective conditions tolerate little, if any, mismatch between the probe and the template or target strand. Detection of DNA sequences via hybridization is well-known to those of skill in the art, and the teachings of U.S. Pat. Nos. 4,965,188 and 5,176,995 are exemplary of the methods of hybridization analyses. "Identity" refers to the degree of similarity between two polynucleic acid or protein sequences. An alignment of the two sequences is performed by a suitable computer program. A widely used and accepted computer program for performing sequence alignments is CLUSTALW vl.6 (Thompson, et al. Nucl. Acids Res., 22: 4673-4680, 1994). The number of matching bases or amino acids is divided by the total number of bases or amino acids, and multiplied by 100 to obtain a percent identity. For example, if two 580 base pair sequences had 145 matched bases, they would be 25 percent identical. If the two compared sequences are of different lengths, the number of matches is divided by the shorter of the two lengths. For example, if there are 100 matched amino acids between a 200 and a 400 amino acid protein, they are 50 percent identical with respect to the shorter sequence. If the shorter sequence is less than 150 bases or 50 amino acids in length, the number of matches are divided by 150 (for nucleic acid bases) or 50 (for amino acids), and multiplied by 100 to obtain a percent identity. As described herein a protein can be "substantially identical" to related proteins. These proteins with substantial identity generally comprise at least one polypeptide sequence that has at least ninety-eight sequence percent identity compared to its related other polypeptide sequence. The Gap program in the WISCONSIN PACKAGE version 10.0-UNIX from Genetics Computer Group, Inc. is based on the method of Needleman and Wunsch (J. Mol. Biol. 48:443-453, 1970) -iB- using the set of default parameters for pairwise comparison (for amino acid sequence comparison: Gap Creation Penalty = 8, Gap Extension Penalty = 20); or using the TBLASTN program in the BLAST 2.2.1 software suite (Altschul et al., Nucleic Acids Res. 25:3389-3402), using BLOSUM62 matrix (Henikoff and Henikoff, Proc. Natl. Acad. Sci. U.S.A. 89:10915- 10919, 1992) and the set of default parameters for pair-wise comparison (gap creation cost =11, gap extension cost =1.). In BLAST, the E-value, or expectation value, represents the number of different alignments with scores equivalent to or better than the raw alignment score, S, that are expected to occur in a database search by chance. The lower the E value, the more significant the match. Because database size is an element in E-value calculations, E-values obtained by "BLASTing" against public databases, such as GenBank, have generally increased over time for any given query/entry match. Percent identity refers to the percentage of identically matched amino acid residues that exist along the length of that portion of the sequences which is aligned by the BLAST algorithm. "Intron" refers to a portion of a gene not translated into protein, even though it is transcribed into RNA. An "isolated" nucleic acid sequence is substantially separated or purified away from other nucleic acid sequences with which the nucleic acid is normally associated in the cell of the organism in which the nucleic acid naturally occurs, i.e., other chromosomal or extrachromosomal DNA. The term embraces nucleic acids that are biochemically purified so as to substantially remove contaminating nucleic acids and other cellular components. The term also embraces recombinant nucleic acids and chemically synthesized nucleic acids. "Isolated," "Purified," "Homogeneous" polypeptides. A polypeptide is "isolated" if it has been separated from the cellular components (nucleic acids, lipids, carbohydrates, and other polypeptides) that naturally accompany it or that is chemically synthesized or recombinant. A monomelic polypeptide is isolated when at least 60% by weight of a sample is composed of the polypeptide, preferably 90% or more, more preferably 95% or more, and most preferably more than 99%. Protein purity or homogeneity is indicated, for example, by polyacrylamide gel electrophoresis of a protein sample, followed by visualization of a single polypeptide band upon staining the polyacrylamide gel; high pressure liquid chromatography; or other conventional methods. Proteins can be purified by any of the means known in the art, for example as described in Guide to Protein Purification, ed. Deutscher, Meth. Enzymol. 185, Academic Press, San Diego, 1990; and Scopes, Protein Purification: Principles and Practice, Springer Verlag, New York, 1982. "Labeling" or "labeled". There are a variety of conventional methods and reagents for labeling polynucleotides and polypeptides and fragments thereof. Typical labels include radioactive isotopes, ligands or ligand receptors, fluorophores, chemiluminescent agents, and enzymes. Methods for labeling and guidance in the choice of labels appropriate for various purposes are discussed, e.g., in Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press (1989) and Current Protocols in Molecular Biology, ed. Ausubel et al., Greene Publishing and Wiley-Interscience, New York, (1992). "Mature protein coding region", this term refers to the sequence of a processed protein product, i.e., a mature EPSP synthase remaining after the chloroplast transit peptide has been removed. "Native", the term "native" generally refers to a naturally-occurring ("wild-type") polynucleic acid or polypeptide. However, in the context of the present invention, some modification of an isolated polynucleotide and polypeptide may have occurred to provide a polypeptide with a particular phenotype, e.g., amino acid substitution in glyphosate sensitive EPSPS to provide a glyphosate resistant EPSPS. For comparative purposes in the present invention, the isolated polynucleotide that contains a few substituted nucleotides to provide amino acid modification for herbicide tolerance is referred to as the "native" polynucleotide when compared to the substantially divergent polynucleotide created by the methods of the present invention. However, the "native" polynucleotide modified in this manner is normative with respect to the genetic elements normally found linked to a naturally occurring unmodified polynucleotide. "N-terminal region" refers to a region of a peptide, polypeptide, or protein chain from the amino acid having a free amino group to the middle of the chain. "Nucleic acid" refers to deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). - Nucleic acid codes: A = adenosine; C = cytosine; G = guanosine; T = thymidine. Codes used for synthesis of oligonucleotides: N = equimolar A, C, G, and T; I = deoxyinosine; K = equimolar G and T; R = equimolar A and G; S = equimolar C and G; W = equimolar A and T; Y = equimolar C and T. A "nucleic acid segment" or a "nucleic acid molecule segment" is a nucleic acid molecule that has been isolated free of total genomic DNA of a particular species, or that has been synthesized. Included with the term "nucleic acid segment" are DNA segments, recombinant vectors, plasmids, cosmids, phagemids, phage, viruses, et cetera. "Nucleotide Sequence Variants", using well-known methods, the skilled artisan can readily produce nucleotide and amino acid sequence variants of genes and proteins, respectively. For example, "variant" DNA molecules of the present invention are DNA molecules containing changes in an EPSPS gene sequence, i.e., changes that include one or more nucleotides of the EPSPS gene sequence is deleted, added, and/or substituted, such that the variant EPSPS gene encodes a protein that retains EPSPS activity. Variant DNA molecules can be produced, for example, by standard DNA mutagenesis techniques or by chemically synthesizing the variant DNA molecule or a portion thereof. Methods for chemical synthesis of nucleic acids are discussed, for example, in Beaucage et al., Tetra. Letts. 22:1859-1862 (1981), and Matteucci et al., J. Am. Chem. Soc. 103:3185- (1981). Chemical synthesis of nucleic acids can be performed, for example, on automated oligonucleotide synthesizers. Such variants preferably do not change the reading frame of the protein-coding region of the nucleic acid and preferably encode a protein having no change, or only a minor reduction. "Open reading frame (ORF)" refers to a region of DNA or RNA encoding a peptide, polypeptide, or protein. "Operably Linked". A first nucleic-acid sequence is "operably" linked with a second nucleic-acid sequence when the first nucleic-acid sequence is placed in a functional relationship with the second nucleic-acid sequence. For example, a promoter is operably linked to a protein- coding sequence if the promoter effects the transcription or expression of the coding sequence. Generally, operably linked DNA sequences are contiguous and, where necessary to join two protein-coding regions, in reading frame. "Overexpression" refers to the expression of a RNA or polypeptide or protein encoded by a DNA introduced into a host cell, wherein the RNA or polypeptide or protein is either not normally present in the host cell, or wherein the RNA or polypeptide or protein is present in said host cell at a higher level than that normally expressed from the endogenous gene encoding the RNA or polypeptide or protein. The term "plant" encompasses any higher plant and progeny thereof, including monocots {e.g., corn, rice, wheat, barley, etc.), dicots (e.g., soybean, cotton, canola, tomato, potato, Arabidopsis, tobacco, etc.), gymnosperms (pines, firs, cedars, etc.) and includes parts of plants, including reproductive units of a plant (e.g., seeds, bulbs, tubers, fruit, flowers, etc. ) or other parts or tissues from that the plant can be reproduced. "Plant expression cassette" refers to chimeric DNA segments comprising the regulatory elements that are operably linked to provide the expression of a transgene product in plants "Plasmid" refers to a circular, extrachromosomal, self-replicating piece of DNA. "Polyadenylation signal" or "polyA signal" refers to a nucleic acid sequence located 3' to a coding region that causes the addition of adenylate nucleotides to the 3' end of the mRNA transcribed from the coding region. "Polymerase chain reaction (PCR)" refers to a DNA amplification method that uses an enzymatic technique to create multiple copies of one sequence of nucleic acid (amplicon). Copies of a DNA molecule are prepared by shuttling a DNA polymerase between two amplimers. The basis of this amplification method is multiple cycles of temperature changes to denature, then re-anneal amplimers (DNA primer molecules), followed by extension to synthesize new DNA strands in the region located between the flanking amplimers. Nucleic-acid amplification can be accomplished by any of the various nucleic-acid amplification methods known in the art, including the polymerase chain reaction (PCR). A variety of amplification methods are known in the art and are described, inter alia, in U.S. Patent Nos. 4,683,195 and 4,683,202 and in PCR Protocols: A Guide to Methods and Applications, ed. Innis et al., Academic Press, San Diego, 1990. PCR amplification methods have been developed to amplify up to 22 kb of genomic DNA and up to 42 kb of bacteriophage DNA (Cheng et al., Proc. Natl. Acad. Sci. USA 91:5695-5699, 1994). These methods as well as other methods known in the art of DNA amplification may be used in the practice of the present invention. Polynucleotide refers to a length of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules greater than two, which are connected to form a larger molecule. Polypeptide fragments. The present invention also encompasses fragments of a protein that lacks at least one residue of a native full-length protein, but that substantially maintains activity of the protein. The term "promoter" or "promoter region" refers to a polynucleic acid molecule that functions as a regulatory element, usually found upstream (5') to a coding sequence, that controls expression of the coding sequence by controlling production of messenger RNA (mRNA) by providing the recognition site for RNA polymerase and/or other factors necessary for start of transcription at the correct site. As contemplated herein, a promoter or promoter region includes variations of promoters derived by means of ligation to various regulatory sequences, random or controlled mutagenesis, and addition or duplication of enhancer sequences. The promoter region disclosed herein, and biologically functional equivalents thereof are responsible for driving the transcription of coding sequences under their control when introduced into a host as part of a suitable recombinant vector, as demonstrated by its ability to produce mRNA. "Recombinant". A "recombinant" nucleic acid is made by a combination of two otherwise separated segments of sequence, e.g., by chemical synthesis or by the manipulation of isolated segments of nucleic acids by genetic engineering techniques. The term "recombinant DNA construct" or "recombinant vector" refers to any agent such as a plasmid, cosmid, virus, autonomously replicating sequence, phage, or linear or circular single-stranded or double-stranded DNA or RNA nucleotide sequence, derived from any source, capable of genomic integration or autonomous replication, comprising a DNA molecule that one or more DNA sequences have been linked in a functionally operative manner. Such recombinant DNA constructs or vectors are capable of introducing a 5' regulatory sequence or promoter region and a DNA sequence for a selected gene product into a cell in such a manner that the DNA sequence is transcribed into a functional mRNA that is translated and therefore expressed. Recombinant DNA constructs or recombinant vectors may be constructed to be capable of expressing antisense RNAs, in order to inhibit translation of a specific RNA of interest. "Regeneration" refers to the process of growing a plant from a plant cell (e.g., plant protoplast or explant). "Reporter" refers to a gene and corresponding gene product that when expressed in transgenic organisms produces a product detectable by chemical or molecular methods or produces an observable phenotype. "Resistance" refers to an enzyme that is able to function in the presence of a toxin, for example, glyphosate resistant class II EPSP synthases. An enzyme that has resistance to a toxin may have the function of detoxifying the toxin, e.g., the phosphinothricin acetyltransferase, glyphosate oxidoreductase, or may be a mutant enzyme having catalytic activity which is unaffected by an herbicide which disrupts the same activity in the wild type enzyme, e.g., acetolactate synthase, mutant class I EPSP synthases. "Restriction enzyme" refers to an enzyme that recognizes a specific palindromic sequence of nucleotides in double stranded DNA and cleaves both strands; also called a restriction endonuclease. Cleavage typically occurs within the restriction site. "Selectable marker" refers to a polynucleic acid molecule that encodes a protein, which confers a phenotype facilitating identification of cells containing the polynucleic acid molecule. Selectable markers include those genes that confer resistance to antibiotics (e.g., ampicillin, kanamycin), complement a nutritional deficiency (e.g., uracil, histidine, leucine), or impart a visually distinguishing characteristic (e.g., color changes or fluorescence). Useful dominant selectable marker genes include genes encoding antibiotic resistance genes (e.g., neomycin phosphotransferase, aad); and herbicide resistance genes (e.g., phosphinothricin acetyltransferase, class IIEPSP synthase, modified class IEPSP synthase). A useful strategy for selection of transformants for herbicide resistance is described, e.g., in Vasil, Cell Culture and Somatic Cell Genetics of Plants, Vols. I-III, Laboratory Procedures and Their Applications Academic Press, New York (1984). The term "specific for (a target sequence)" indicates that a DNA probe or DNA primer hybridizes under given hybridization conditions only to the target sequence in a sample comprising the target sequence. The term "substantially purified", as used herein, refers to a molecule separated from other molecules normally associated with it in its native state. More preferably, a substantially purified molecule is the predominant species present in a preparation. A substantially purified molecule may be greater than 60% free, preferably 75% free, more preferably 90% free from the other molecules (exclusive of solvent) present in the natural mixture. The term "substantially purified" is not intended to encompass molecules present in their native state. "Tolerant" or "tolerance" refers to a reduced effect of a biotic or abiotic agent on the growth and development of organisms and plants, e.g. a pest or a herbicide. "Transcription" refers to the process of producing an RNA copy from a DNA template. "Transformation" refers to a process of introducing an exogenous polynucleic acid molecule (e.g., a DNA construct, a recombinant polynucleic acid molecule) into a cell or protoplast and that exogenous polynucleic acid molecule is incorporated into a chromosome or is capable of autonomous replication. "Transformed" or "transgenic" refers to a cell, tissue, organ, or organism into which a foreign polynucleic acid, such as a DNA vector or recombinant polynucleic acid molecule. A "transgenic" or "transformed" cell or organism also includes progeny of the cell or organism and progeny produced from a breeding program employing such a "transgenic" plant as a parent in a cross and exhibiting an altered phenotype resulting from the presence of the foreign polynucleic acid molecule. The term "transgene" refers to any polynucleic acid molecule normative to a cell or organism transformed into the cell or organism. "Transgene" also encompasses the component parts of a native plant gene modified by insertion of a normative polynucleic acid molecule by directed recombination or site specific mutation. "Transit peptide" or "targeting peptide" molecules, these terms generally refer to peptide molecules that when linked to a protein of interest directs the protein to a particular tissue, cell, subcellular location, or cell organelle. Examples include, but are not limited to, chloroplast transit peptides, nuclear targeting signals, and vacuolar signals. The chloroplast transit peptide is of particular utility in the present invention to direct expression of the EPSPS enzyme to the chloroplast. The term "translation" refers to the production the corresponding gene product, i.e., a peptide, polypeptide, or protein from a mRNA. "Vector" refers to a plasmid, cosmid, bacteriophage, or virus that carries foreign DNA into a host organism. Polynucleotides Methods of the present invention include designing genes that confer a trait of interest to the plant into which they are introduced. The transgenes of agronomic interest that provide beneficial agronomic traits to crop plants, for example, including, but not limited to genetic elements comprising herbicide resistance (US Patent No. 5,633,435; US Patent No. 5,463,175), increased yield (US Patent No. 5,716,837), insect control (US Patent No. 6,063,597; US Patent No. 6,063,756; US Patent No. 6,093,695; US Patent No. 5,942,664; US Patent No. 6,110,464), fungal disease resistance (US Patent No. 5,516,671; US Patent No. 5,773,696; US Patent No. 6,121,436; and US Patent No.6,316,407, and US Patent No. 6,506,962), virus resistance (US Patent No. 5,304,730 and US Patent No. 6,013,864), nematode resistance (US Patent No. 6,228,992), bacterial disease resistance (US Patent No. 5,516,671), starch production (US Patent No. 5,750,876 and US Patent No. 6,476,295), modified oils production (US Patent No. 6,444,876), high oil production (US Patent No. 5,608,149 and US Patent No. 6,476,295), modified fatty acid content (US Patent No. 6,537,750), high protein production (US Patent No. 6,380,466), fruit ripening (US Patent No. 5,512,466), enhanced animal and human nutrition (US Patent No. 5,985,605 and US Patent No. 6,171,640), biopolymers (US Patent No. 5,958,745 and US Patent Publication No. US20030028917), environmental stress resistance (US Patent No. 6,072,103), pharmaceutical peptides (US Patent No. 6,080,560), improved processing traits (US Patent No. 6,476,295), improved digestibility (US Patent No. 6,531,648) low raffinose (US Patent No. 6,166,292), industrial enzyme production (US Patent No. 5,543,576), improved flavor (US Patent No. 6,011,199), nitrogen fixation (US Patent No. 5,229,114), hybrid seed production (US Patent No. 5,689,041), and biofiiel production (US Patent No. 5,998,700), the genetic elements and transgenes described in the patents listed above are herein incorporated by reference. Herbicides for which transgenic plant tolerance has been demonstrated and the method of the present invention can be applied, include but are not limited to: glyphosate, glufosinate, sulfonylureas, imidazolinones, bromoxynil, delapon, cyclohezanedione, protoporphyrionogen oxidase inhibitors, and isoxasflutole herbicides. Polynucleotide molecules encoding proteins involved in herbicide tolerance are known in the art, and include, but are not limited to a polynucleotide molecule encoding 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS, described in U.S. Patent Nos. 5,627,061, 5,633,435, 6,040,497; Padgette et al. Herbicide Resistant Crops, Lewis Publishers, 53-85, 1996; and Penaloza-Vazquez, et al. Plant Cell Reports 14:482-487, 1995; and aroA (U.S. Patent No. 5,094,945) for glyphosate tolerance; bromoxynil nitrilase (Bxri) for Bromoxynil tolerance (U.S. Patent No. 4,810,648); phytoene desaturase (crtl, Misawa et al, (1993) Plant J. 4:833-840, and (1994) Plant J. 6:481-489); for tolerance to norflurazon, acetohydroxyacid synthase (AHAS, aka ALS, Sathasiivan et al. Nucl. Acids Res. 18:2188-2193, 1990); and the bar gene for tolerance to glufosinate and bialaphos (DeBlock, et al. EMBO J. 6:2513-2519,1987). Herbicide tolerance is a desirable phenotype for crop plants. N-phosphonomethylglycine, also known as glyphosate, is a well known herbicide that has activity on a broad spectrum of plant species. Glyphosate is the active ingredient of Roundup® (Monsanto Co.), a safe herbicide having a desirably short half life in the environment When applied onto a plant surface, glyphosate moves systemically through the plant. Glyphosate is toxic to plants by inhibiting the shikimic acid pathway, which provides a precursor for the synthesis of aromatic amino acids. Specifically, glyphosate affects the conversion of phosphoenolpyruvate and 3-phosphoshikimic acid to 5-enolpyruvyl-3-phosphoshikimic acid by inhibiting the enzyme 5-enolpyruvyl-3- phosphoshikimate synthase (hereinafter referred to as EPSP synthase or EPSPS). For purposes of the present invention, the term glyphosate" should be considered to include any herbicidally effective form of N-phosphonomethylglycine (including any salt thereof) and other forms which result in the production of the glyphosate anion in planta. Through plant genetic engineering methods, it is possible to produce glyphosate tolerant plants by inserting into the plant genome a DNA molecule that causes the production of higher levels of wild-type EPSPS (Shah et al., Science 233:478-481, 1986). Glyphosate tolerance can also be achieved by the expression of EPSPS variants that have lower affinity for glyphosate and therefore retain their catalytic activity in the presence of glyphosate (U.S. Patent No. 5,633,435). Enzymes that degrade glyphosate in the plant tissues (U.S. Patent No. 5,463,175) are also capable of conferring cellular tolerance to glyphosate. Such genes, therefore, allow for the production of transgenic crops that are tolerant to glyphosate, thereby allowing glyphosate to be used for effective weed control with minimal concern of crop damage. For example, glyphosate tolerance has been genetically engineered into corn (U.S. Patent No. 5,554,798, 6,040,497), wheat (Zhou et al. Plant Cell Rep. 15:159-163,1995), soybean (WO 9200377) and canola (WO 9204449). Variants of the wild-type EPSPS enzyme have been isolated that are glyphosate-resistant as a result of alterations in the EPSPS amino acid coding sequence (Kishore et al., Annu. Rev. Biochem. 57:627-663,1988; Schulz et al., Arch. Microbiol. 137:121-123, 1984; Sost et al., FEBS Lett. 173:238-241, 1984; Kishore et al., In "Biotechnology for Crop Protection" ACS Symposium Series No. 379. eds. Hedlin et al., 37-48,1988). These variants typically have a higher Ki for glyphosate than the wild-type EPSPS enzyme that confers the glyphosate-tolerant phenotype, but these variants are also characterized by a high Km for PEP that makes the enzyme kinetically less efficient. For example, the apparent Km for PEP and the apparent Kj for glyphosate for the native EPSPS from E. coli are 10 |iM and 0.5 |xM while for a glyphosate- resistant isolate having a single amino acid substitution of an alanine for the glycine at position 96 these values are 220 pM and 4.0 mM, respectively. US Patent No. 6,040,497 reports that the mutation known as the TIPS mutation (a substitution of isoleucine for threonine at amino acid position 102 and a substitution of serine for proline at amino acid position 106) comprises two mutations that when introduced into the polypeptide sequence of Zea mays EPSPS confers glyphosate resistance to the enzyme. Transgenic plants containing this mutant enzyme are tolerant to glyphosate. Identical mutations may be made in glyphosate sensitive EPSPS enzymes from other plant sources to create glyphosate resistant enzymes. A variety of native and variant EPSPS enzymes have been expressed in transgenic plants in order to confer glyphosate tolerance (Singh, et al., In "Biosynthesis and Molecular Regulation of Amino Acids in Plants", Amer Soc Plant Phys. Pubs., 1992). Examples of some of these EPSPSs include those described and/or isolated in accordance with U.S. Patent No. 4,940,835, U.S. Patent No. 4,971,908, U.S. Patent No. 5,145,783, U.S. Patent No. 5,188,642, U.S. Patent No. 5,310,667, and U.S. Patent No. 5,312,910. They can also be derived from a structurally distinct class of non-homologous EPSPS genes, such as the class II EPSPS genes isolated from Agrobacterium sp. strain CP4 as described in U.S. Patent No. 5,633,435 and U.S. Patent No. 5,627,061. Chloroplast transit peptides (CTPs) are engineered to be fused to the N terminus of the bacterial EPSPS to direct the glyphosate resistant enzymes into the plant chloroplast. In the native plant EPSPS, chloroplast transit peptide regions are contained in the native coding sequence (e.g., CTP2, Klee et al., Mol. Gen. Genet. 210:47-442, 1987, herein incorporated by reference in its entirety). The native CTP may be substituted with a heterologous CTP during construction of a transgene plant expression cassette. Many chloroplast-localized proteins, including EPSPS, are expressed from nuclear genes as precursors and are targeted to the chloroplast by a chloroplast transit peptide (CTP) that is removed during the import steps. Examples of other such chloroplast proteins include the small subunit (SSU) of Ribulose-1,5,- bisphosphate carboxylase, Ferredoxin, Ferredoxin oxidoreductase, the light-harvesting complex protein I and protein II, and Thioredoxin F. It has been demonstrated in vivo and in vitro that non-chloroplast proteins may be targeted to the chloroplast by use of protein fusions with a CTP and that a CTP sequence is sufficient to target a protein to the chloroplast. Incorporation of a suitable chloroplast transit peptide, such as, the Arabidopsis thaliana EPSPS CTP (Klee et al., Mol. Gen. Genet. 210:437-442 (1987), and the Petunia hybrida EPSPS CTP (della-Cioppa et al., Proc. Natl. Acad. Sci. USA 83:6873-6877 (1986) has been shown to target heterologous EPSPS protein sequences to chloroplasts in transgenic plants. The production of glyphosate tolerant plants by expression of a fusion protein comprising an amino-terminal CTP with a glyphosate resistant EPSPS enzyme is well known by those skilled in the art, (U.S. Patent No. 5,627,061, U.S. Patent No. 5,633,435, U.S. Patent No. 5,312,910, EP 0218571, EP 189707, EP 508909, and EP 924299). Those skilled in the art will recognize that various chimeric constructs can be made that utilize the functionality of a particular CTP to import glyphosate resistant EPSPS enzymes into the plant cell chloroplast. Modification and changes may be made in the structure of the polynucleotides of the invention and still obtain a molecule that encodes a functional protein or peptide with desirable characteristics. The following is a method based upon substituting the codon(s) of a first polynucleotide to create an equivalent, or even an improved, second-generation artificial polynucleotide, where this new artificial polynucleotide is useful in methods of transgene gene stacking and enhanced expression. It is contemplated that the codon substitutions in the second- generation polynucleotide can in certain instances result in at least one amino acid different from that of the first polynucleotide. The amino acid substitution may provide an improved characteristic to the protein, e.g., a glyphosate resistant EPSP synthase, or it may be a conserved change that does not substantially affect the characteristics of the protein. The method provides for an artificial polynucleotide created by the backtranslation of a polypeptide sequence into a polynucleotide using a codon usage table, followed by steps to enhance characteristics of the artificial polypeptide that make it particularly useful in transgenic plants. In particular embodiments of the invention, modified polypeptides encoding herbicide resistant proteins are contemplated to be useful for at least one of the following: to confer herbicide tolerance in a transformed or transgenic plant, to improve expression of herbicide resistance genes in plants, for use as selectable markers for introduction of other traits of interest into a plant, and to prevent recombination with a similar endogenous plant gene or existing transgene further allowing gene stacking without gene silencing. It is known that the genetic code is degenerate. The amino acids and their RNA codon(s) are listed below in Table 1. TABLE 1. Amino acids and the RNA codons that encode them. Amino Acid Codons Full name; 3 letter code; 1 letter code Alanine; Ala; A GCA GCC GCG GCU Cysteine; Cys; C UGC UGU Aspartic acid; Asp; D GAC GAU Glutamic acid; Glu; E GAA GAG Phenylalanine; Phe; F UUC UUU Glycine; Gly; G GGA GGC GGG GGU Histidine; His; H CAC CAU Isoleucine; lie; I AUA AUC AUU Lysine; Lys; K AAA AAG Leucine ; Leu; L UUA UUG CUA CUC CUG CUU Methionine; Met; M AUG Asparagine; Asn; N AAC AAU Proline; Pro; P CCA CCC CCG CCU Glutamine; Gin; Q CAA CAG Arginine; Arg; R AGA AGG CGA CGC CGG CGU Serine; Ser; S AGC AGU UCA UCC UCG UCU Threonine; Thr; T ACA ACC ACG ACU Valine; Val; V GUA GUC GUG GUU Tryptophan; Trp; W UGG Tyrosine; Tyr; Y UAC UAU The codons are described in terms of RNA bases, e.g. adenine, uracil, guanine and cytosine, it is the mRNA that is directly translated into polypeptides. It is understood that when designing a DNA polynucleotide for use in a construct, the DNA bases would be substituted, e.g. thymine instead of uracil. It is desirable to provide transgenic plants that have multiple agronomically improved phenotypes. Often herbicide tolerance is used as a selectable marker to assist in the production of transgenic plants that may possess additional genes of agronomic importance. The stacking of the transgenes by traditional breeding methods or by retransformation of a first transgenic plant with an additional plant expression cassette may include the introduction of genes or genetic elements that have identical or nearly identical polynucleotide sequence. The progeny containing these stacked genes may be susceptible to loss of gene expression due to gene silencing. The method of the present invention provides a modified polynucleotide molecule that encodes a herbicide resistant protein. The polynucleotide molecules are designed to be sufficiently divergent in polynucleotide sequence from other polynucleotide molecules that encode the same herbicide resistance protein. These molecules can then coexist in the same plant cell without the concern of gene silencing. The divergent polynucleotide sequence is created by using a codon usage table built from the known coding sequences of various plant species. For example, codon usage tables for Arabidopsis thaliana, Zea mays, and Glycine max can be used in the method to design the polynucleotides of the present invention. Other codon usage tables from other plants can also be used by those of ordinary skill in the art. The first step in the method for designing a new artificial polynucleotide molecule that encodes a herbicide tolerance protein is the use of a codon usage table to determine the percent codon usage in a plant species for each amino acid of the herbicide tolerance protein, followed by replacing at least one of every eight contiguous codons with a different codon selected from the codon usage table and adjusting the percent codon usage for each amino acid encoded by the polynucleotide to substantially the same percent codon usage found in the codon usage table. Additional steps can include introducing a translational stop codon in the second and third open reading frame of the new polynucleotide sequence; eliminating some translational start codons in the second and third open reading frames; adjusting the local GC:AT ratio to about 2:1 over a range of about 50 nucleotides; disrupting potential polyadenylation signals or potential intron splice sites; removing at least one restriction enzyme site of six contiguous nucleotides or greater; and comparing the sequence identity of the new artificial polynucleotide to an existing polynucleotide that encodes the same or similar protein so that the sequence identity between the two polynucleotides is not more than 85 percent. A back translation of a protein sequence to a nucleotide sequence maybe performed using a codon usage table, such as those found on Genetics Computer Group (GCG) SeqLab or other DNA analysis programs known to those skilled in the art of DNA analysis or as provided in Tables 2, 3 and 4 of the present invention. The codon usage table for Arabidopsis thaliana (Table 2), Zea mays (Table 3) and Glycine max (Table 4) are examples of tables that can be constructed for plant species, codon usage tables can also be constructed that represent monocot or dicot codon usage. searchable through this World Wide Web site (Nakamura et al. Nucleic Acids Res.28:292, 2000). In various embodiments of the invention, the steps may be performed in any order or simultaneously. Any or all of the steps may be performed in the design of an artificial polynucleotide of the invention. Each step is described in detail below. Different codons for a particular amino acid should be distributed throughout the polynucleotide based on approximate percentage codon usage for particular species from a codon usage table. Local cluster of identical codons should be avoided. At least one codon is substituted for every eight contiguous codons to provide sufficient divergence of polynucleotide sequences that encode identical or similar proteins. Except where specifically desired, e.g. to provide a herbicide tolerant enzyme, the encoded protein remains unchanged by substituting one codon for another codon that is translated to the same amino acid as listed in Table 1. In embodiments of the present invention, corrections are made to the local GC:AT ratio of a polynucleotide by adjusting local GC:AT ratio to be about the same ratio as the full length polynucleotide, but not higher than 2X over a range of about 50 contiguous nucleotides of the polynucleotide molecule. The range of GC:AT ratios of a polynucleotide using codon usage tables from dicot plants should be from about 0.9 to about 1.3, and for monocot plants from about 1.2 to about 1.7. The local GC:AT ratio may be important in maintenance of appropriate secondary structure of RNA. Regions comprising many consecutive A+T bases or G+C bases are predicted to have a higher likelihood to form hairpin structures due to self-complementarity. Therefore, replacement with a different codon would reduce the likelihood of self- complementary secondary structure formation, which is known to reduce transcription and/or translation in some organisms. In most cases, the adverse effects may be minimized by using polynucleotide molecules that do not contain more than five consecutive A+T or G+C. The maximum length of local GC track (without any AT nucleotide) should be no longer than 10 nucleotides. Therefore codons encoding Gly, Ala, Arg, Ser, and Pro rich proteins can be substituted to prevent long clusters of GC nucleotides. The listed GC rich codons may be used in combination with the AT rich codons for amino acids Lys, Asn, He, Tyr, Leu, Phe and vice versa to correct local GC:AT ratio. A sequence identity check using nucleotide sequence alignment tools such as GAP program (GCG, Madison, WI) can be done immediately after back translation to insure that the generated sequence has appropriate degree of sequence diversity. Contiguous polynucleotide sequence longer than 23 nucleotides having one hundred percent sequence identity should be eliminated by making codon substitutions in these lengths of sequence. The translational start codons (ATG from the DNA, AUG in the mRNA) present in the second reading frame (frame "b"), the third reading frame (frame "c"), and the reverse reading frames (frame "d", "e", "f')• The second and third frame start codons may initiate translation, however much less efficiently than the first. Therefore, if one or two AUG are found near the 5' end of an mRNA molecule reside in frame "b" or "c" it would be beneficial to eliminate them in a polynucleotide region that contains at least the first three Met codons in frame "a". Also, if protein sequence does not have more than one Met in frame "a", then eliminate as many as possible from the "b" or "c" forward frames. To perform this, for example, the codons for amino acids, Asp, Asn, Tyr, His in the protein of interest followed by any of the amino acids: Gly, Glu, Asp, Val, or Ala, can be substituted to eliminate a start codon in the second frame. The sequence GATGGG encodes the amino acids Asp-Gly and forms an ATG in the reading frame "b". When the sequence is modified to GACGGG, the ATG start is eliminated and the sequence still encodes Asp-Gly. A similar strategy is used to eliminate start codons in the reading frame "c". The combination of an amino acid selected from the group of Gly, Glu, Val, Ala, Arg, Lys, lie, Thr, Cys, Tyr, Leu, Ser, His or Pro followed by Trp can result in formation on ATG in third reading frame of the gene. In this situation, the first codon can be changed to have a nucleotide other than A in third position. The elimination of ATG codon in the complementary DNA strand of the gene in alternate frames ("d", "e", and/or "f') without changing amino acid sequence of the protein can be accomplished in a similar manner. This modification reduces the probability of translation even if the transgene is integrated into a plant genome in an orientation that allows transcription of the reverse complement mRNA from a native plant promoter. Translation from any reverse reading frame can be minimized by introduction of a stop codon in all three reverse reading frames as described below. The creation of stop codons to all three frames of the complementary DNA can be accomplished as follows. The Leu (TTA and CTA) and Ser codon (TCA) produce three different stop codons in reverse complement strand. If those amino acids can be found at the C terminus of the protein of interest, their codons may used to generate stops in the complementary strand in the reading frame "d". To generate a stop codon in the reading frame "e" of complementary strand, find amino acids Ala, Arg, Asn, Asp, Cys, Gly, His, lie, Leu Phe, Pro, Ser, Thr, Tyr, or Val followed by amino acids Gin, His or Tyr the protein of interest. For example, polynucleotide sequence of GCCCAC that encode for amino acids Ala-His can be modified to GCTCAC. The complementary sequence, GTGAGC, will have now TGA stop codon shown in italics. When the protein of interest has a Ala, lie, Leu, Phe, Pro, Ser, Thr or Val followed by an Arg, Asn, lie, Lys, Met, or Ser the reading frame in the complementary strand can be modified to have a stop codon in the reading frame "f' of the complementary strand. The polynucleotide sequence ATATCT for lie and Ser can be modified to ATCAGT to generate stop codon in complementary strand as shown in italics, ACTGAT. The combination of codons for Phe followed by any of the codons for amino acids Asn, lie, Lys, Met or Thr will always generate stop codon in complementary strand frame "e " or "f To create a stop codon in the forward reading frame "b", the reading frame a must end on nucleotides TA or TG. Search the protein of interest for the amino acids lie, Leu, Met or Val in combination with any of the following amino acids: Ala, Arg, Asn Asp, Glu, Gly, He, Lys, Met, Ser, Thr or Val. For example, if the polynucleotide sequence encoding the amino acids Met-Ser is ATGTCT, it can be modified to ATGAGT to produce a TGA stop codon in second reading frame. To be able to create a stop codon to the reading frame "c", the reading frame "a" must have the nucleotide T in third position and next codon must start from AA, AG or GA. To find suitable codons to modify, search the protein of interest for any of the amino acids: Ala, Asn, Asp, Arg, Cys, Gly, His, He, Leu Phe, Pro, Ser, Thr, Tyr or Val follow by any of the following amino acids: Arg, Asn, Asp, Glu, Lys or Ser. For example, if the nucleotide sequence for amino acids Gly-Glu is GGAGAG, the sequence can be modified to GGTGAG to create a TGA stop codon in the third reading frame. Another useful modification in artificial polynucleotide design methods of the present invention is to eliminate unwanted restriction sites and other specific sequence patterns. Restriction sites may interfere with future gene cloning and manipulations. For example, some restriction sites commonly used in gene cloning include, but are not limited, to the Type II restriction enzymes with 6 or more non-N bases listed in Table 5 below which is an excerpt from the New England Biolabs, Inc. (Beverly, MA, USA) restriction endonuclease database. The search for restriction enzyme recognition sites can be done using Map function application found in GCG SeqLab or a similar application contained in other DNA analysis programs known to those skilled in the art of DNA analysis. The restriction enzymes can be also added to the sequence to facilitate cloning. For example, The Clal restriction site is placed in CP4EPSPS version AT (SEQ ID NO: 17) and ZM (SEQ ED NO: 18) to generate recombinant sequences by fragment exchange and to facilitate gene synthesis using nucleotide fragments that can be assemble to the whole gene. The transit peptide CTP2 polynucleotide sequence (SEQ ID NO: 12) is connected with CP4EPSPS by SphI restriction site to facilitate substitution of CTP2 with different nucleotide versions of CTP2 (SEQ ID NO: 13, SEQ ID NO: 14) or polynucleotides encoding different chloroplast transit peptides. For example, in the rice EPSPS, the NgaMTV restriction site is preserved at about nucleotide position 205 in all artificial versions to facilitate chloroplast transit peptide coding region exchange. Also, for soybean EPSPS the polynucleotide sequence for the chloroplast transit peptide is separated from the mature peptide by the restriction site for SacII endonuclease. It is understood that modification of endonuclease restriction sites is not required, but is useful for further manipulation of the DNA molecules. Table 5 provides a list of restriction endonucleases, those of particular interest to the present invention are marked with an asterisk. Other endonuclease restriction sites desirable for elimination or addition to an artificial polynucleotide of the present invention will be apparent to those of ordinary skill in the art and are not limited to those listed in Table 5. TABLE 5. Restriction enzymes recognition sequences Enzymes Recognition Sequence Enzymes Recognition Sequence AatH G ACGTX: Asun TFCG AA *AccI GTAMK AC Aval CAYCGR G Acc65I GXJTAC C AvaHI ATGCAT Acell G CTAGX: - Avrll CCTAG G Acll AA*CG IT BaH TGCCCA Acyl GR'XXJ YC ♦BamHI G^MjrATC C Afel AGCAGCT BanI G^GYRC C Aflll CATTAA G BanD G RGCY^ *Afim A*CRYG T *BbeI G GCGC^ Agel A^CCGG T BbvCI CCATCA GC Ahalll TTPAAA *BclI T-XJATC A Apal G GGCC^C Betl W^CGG W ApaLI GATGCA C BfrBI ATGCAT Apol RAAATT Y *Bgin A^ATC T AscI GG^GCG CC BloHH CTGCAAG Asel ATATA AT BlpI GCATNA GC AsiSI GCG AT'CGC Bme15801 G KGCIVTC Enzymes Recognition Sequence Bmgl GKGCCC BpulOI CCATNA GC Bsal GGTCTCNANNNN BsaAI YACXiTR BsaHI GR^G YC BsaWI W^CGG W Bsbl CAACAC BsePI G^GCG C BseSI G KGCM-^C Bsil CAACGA G BsiEI CG RY^G BsiWI C^TAC G BsmI GAATG CNA Bspl286I G DGCH^ Bsp14071 T-XiTAC A BspEI T^CCGG A BspGI CTGGAC BspHI TCATG A BspLUllI A^ATG T BspMH T^CGG A BsrBI CCG*CTC BsrDI GCAATG NNA BsrFI R^CGG Y BsrGI TOTAC A BssHH G^CGCG C BssSI CAACGA G BstAPI GCAN NNNANTGC BstBI TTCG AA BstEII G^TNAC C BstXI CCAN NNNNANTGG BstYT R'XjATC Y BstZ17I GTAATAC Bsu36I CCATNA GG Btgl C^RYG G Btrl CAC^TC BtsI GCAGTG NNA CM YAGGCC R CfrlOI R^CGG Y *ClaI AT^G AT Dral TTPAAA Drall RG^GNC CY Drdll GAACCA Dsal C^RYG G Eael YAGGCC R EagI CAGGCC"G Ecll36II GAG^TC Enzymes Recognition Sequence Eco47m AGCAGCT EcoNI CCTNNAN NNAGG Eco0109I RG^GNC CY *EcoRI GAAATT C *EcoRV GATAATC Espl GCATNA GC *FseI GG CCGG^C *FspI TGCAGCA FspAI RTGCAGCAY Gdill CAGGCC R Hael WGG^CW HaeH R GCGCAY HgiAI G WGCW^C HgiCI C^GYRC C HgiJU G RGCY^ ♦Hincn GTYARAC Hindll GTYARAC ♦Hindlll AAAGCT T *HpaI GTTAAAC KasI G^GCGC C *KpnI G GTAC^ Lpnl RGCAGCY Mcrl CG RY^G Mfel CAAATT G *MluI A^GCG T MscI TGG^CA MspAlI CMG^KG MstI TGCAGCA Nael GCCAGGC Narl GG^G CC *NcoI CCATG G *NdeI CAATA TG ♦NgoMTV G^CGG C *NheI G^TAG C Nli3877I C YCGR'XJ *NotI GCAGGCC GC *NruI TCG^GA *NsiI A TGCAAT Nspl R CATGAY NspBII CMG^KG *PacI TTA ATATAA *PciI AACATG T Pfll 1081 TCGTAG *PflMI CCAN NNNANTGG PmaCI CACAGTG Pmel GTTTAAAAC Recognition Sequence CACAGTG AATGCA_T RGXJWCCY GACNNANNGTC TTAATAA GAGGCC_C RG_GNCACY C_TGCAAG CG_ATACG CAG^TG CG'XjWCCG G_AGCTAC CC_GCAGG GATCGA_C GG^GWCCC GCTCTTCNANNN_ CCATNA_GG CC_TGCAAGG AGTAACT CTCAGAG G_DGCHAC A'XCWGGT CATRYA_G CATRYA_G GGCCN_NNNANGGCC GGCXJCC GCG_ATACGC CRACCGG_YG CCCAGGG CATYRA_G GTATAC TAC^TA A^TAGT G.CATG^ CAGTAC_G GCCCXjGGC CG^CCGGCG CC_TGCAAGG AG*GWC_CT AATAATT AGG^CT CACWWG_G ATTTAAAAT WAGTAC_W TCCNGGA Enzymes Pmll PpulOI *PpuM3 PshAI Psil ♦PspOMI PssI *PstI *PvuI *PvuH Rsrll *SacI *SacH ♦Sail SanDI Sapl Saul Sbfl *ScaI Scil Sdul SexAI Sfcl Sfel Sfil Sfol Sgfl SgrAI *SmaI Smll Snal *SnaBI *SpeI *SphI SplI Srfl Sse232I Sse8387I Sse8647I *SspI *StuI ♦Styl *SwaI TatI UbaMI UbaPI CGAACG Enzymes Recognition Sequence *VspI ATATA_AT *XbaI TACTAG_A *XhoI CATCGA_G Xhon RAGATC_Y *XmaI CACCGG_G Xmalll CAGGCC_G XmnI GAANNANNTTC Zral GAC^TC A pattern search may be performed to find potential destabilizing sequences and polyadenylation sites and then disrupt or eliminate them as described in US Patent No. 5,500,365. Certain long stretches of AT rich regions, e.g. the sequence motif ATTTA (or AUUUA, as it appears in RNA) have been implicated as a destabilizing sequence in mammalian 5 cell mRNA (Shaw and Kamen, Cell 46:659-667, 1986). Many short lived mRNAs have A+T rich 3' untranslated regions, and these regions often have the ATTTA sequence, sometimes present in multiple copies or as multimers (e.g., ATTTATTTA ...). Shaw and Kamen showed that the transfer of the 31 end of an unstable mRNA to a stable RNA (globin or VA1) decreased the stable RNA's halflife dramatically. They further showed that a pentamer of ATTTA had a 10 profound destabilizing effect on a stable message, and that this signal could exert its effect whether it is located at the 3' end or within the coding sequence. However, the number of ATTTA sequences and/or the sequence context in which they occur also appear to be important in determining whether they function as destabilizing sequences. They also showed that a trimer of ATTTA had much less effect than a pentamer on mRNA stability and a dimer or a monomer is had no effect on stability. Note that multimers of ATTTA such as a pentamer automatically create an A+T rich region- In other unstable mRNAs, the ATTTA sequence may be present in only a single copy, but it is often contained in an A+T rich region. A repeat of 11 AUUUA pentamers has been shown to target reporter transcripts for rapid degradation in plants (Ohme- Takagi et al, Proc. Nat. Acad. Sci. USA 90, 11811-11815, 1993). ATTTA sequence can be 20 formed by combination of codons for amino acid lie (ATT) and Tyr (TAT) as shown ATTTAT. Another example could be codons that end on AT as in Asn, Asp, His or Tyr, followed by TTA codon for Leu (e.g. AATTTA). Also codon for Phe (UUU) when placed between codons that ends on A and starts on A will form ATTTA motif. To eliminate this motif usually single nucleotide change is sufficient as in example shown: GCATTTAGC change to GCATTCAGC or 25 GCCTTTAGC. All three polynucleotide shown code for Ala-Phe-Arg. More cis-acting sequences that target transcript for rapid turnover in plants and in other system has been identified (Abler and Green, Plant Mol. Biol. 32:63-78, 1997). Those include the DST element that consist three highly conserved subdomains separated by two variable regions found downstream of the stop codon of SAUR transcripts (Newmaan et al., Plant Cell 5: 30 701-714, 1993). The DST conserved sequence consist of GGy4G(N5)C4L4G^77G(N7)CATnTGL4r, where highly conserved residues are shown in italics type. The second and third subdomains of DST elements contain residues that are invariant among DST elements and are termed ATAGAT and GTA, respectively. Both of those subdomains are necessary for DST function. New artificial polynucleotide sequences are screened for the presence of conserved motifs of DST elements GGAG, ATAGATT, CATTT and CATTTTGTAT. Those sequences are eliminated by base substitutions of codons preserving protein sequence encoded by the polynucleotide. The DST sequence motifs GGAG, ATAGAT, CATTT and GTAT that appeared in clusters or patterns similar to the conserved DST sequence are also eliminated by base substitutions. Polynucleotide sequences that may possibly function as polyadenylation sites are eliminated in the new polynucleotide design (U.S. Patent No. 5,500,365). These polyadenylation signals may not act as proper polyA sites, but instead function as aberrant sites that give rise to unstable mRNAs. The addition of a polyadenylate string to the 3' end of a mRNA is common to most eukaryotic mRNAs. Contained within this mRNA transcript are signals for polyadenylation and proper 31 end formation. This processing at the 3' end involves cleavage of the mRNA and addition of polyA to the mature 3' end. By searching for consensus sequences near the polyA tract in both plant and animal mRNAs, it has been possible to identify consensus sequences that apparently are involved in polyA addition and 3' end cleavage. The same consensus sequences seem to be important to both of these processes. These signals are typically a variation on the sequence AATAAA. In animal cells, some variants of this sequence that are functional have been identified; in plant cells there seems to be an extended range of functional sequences (Dean et al., Nucl Acid Res., 14:2229-2240, 1986; Hunt, Annu Rev. Plant Physiol. Plant Mol. Biol 45:47-60,1994; Rothine, Plant Mol. Biol. 32:43-61,1996). All of these consensus sequences are variations on AATAAA, therefore, they all are A+T rich sequences. Typically, to obtain sufficient expression of modified transgenes in plants, existing structural polynucleotide coding sequence ("structural gene") that encodes for the protein of interest is modified by removal of ATTTA sequences and putative polyadenylation signals by site directed mutagenesis of the DNA comprising the structural gene. Substantially all of the known polyadenylation signals and ATTTA sequences are removed in the modified polynucleotide, although enhanced expression levels are often observed with only removal of some of the above identified polyadenylation signal sequences. Alternately, if an artificial polynucleotide is prepared that encodes for the subject protein, codons are selected to avoid the ATTTA sequence and putative polyadenylation signals. For purposes of the present invention putative polyadenylation signals include, but are not necessarily limited to, AATAAA, AATAAT, AACCAA, ATATAA, AATCAA, ATACTA, ATAAAA, ATGAAA, AAGCAT, ATTAAT, ATACAT, AAAATA, ATT AAA, AATTAA, AATACA and CATAAA. The selected DNA sequence is scanned to identify regions with greater than four consecutive adenine (A) or thymine (T) nucleotides. The A+T regions are scanned for potential plant polyadenylation signals. Although the absence of five or more consecutive A or T nucleotides eliminates most plant polyadenylation signals, if there are more than one of the minor polyadenylation signals identified within ten nucleotides of each other, then the nucleotide sequence of this region is altered to remove these signals while maintaining the original encoded amino acid sequence. The next step is to consider the about 15 to about 30 or so nucleotide residues surrounding the A+T rich region. If the A+T content of the surrounding region is less than 80%, the region should be examined for polyadenylation signals. Alteration of the region based on polyadenylation signals is dependent upon (1) the number of polyadenylation signals present and (2) presence of a major plant polyadenylation signal. The polyadenylation signals are removed by base substitution of the DNA sequence in the context of codon replacement. Two additional patterns not identified in US Patent No. 5,500,365, are searched for and eliminated in embodiments of the present invention. The sequences AGGTAA and GCAGGT are consensus sequences for intron 5' and 3' splice sites, respectively, in monocot plants and dicot plants. Only GT of the 5' splice site and the AG in the 3' splice site are required to be an exact match. However, when conducting a search for these consensus sequences, no mismatch is allowed for each base. After each step sequence mapping is done using MAP program from GCG to determine location of the open reading frames and identify sequence patterns that further need to be modified. The final step would be to perform sequence identity analysis using for example the GAP program from GCG package to determine degree of sequence divergence and percent identity. Polypeptides Generally, the translated protein of the artificial polynucleotide will have the same amino acid sequence as the protein translated from the unmodified coding region. However, the substitution of codons that encode for amino acids that provide a functional homologue of the 5 protein is an aspect of the invention. For example, certain amino acids may be substituted for other amino acids in a protein structure without appreciable loss of interactive binding capacity with structures such as, for example, antigen-binding regions of antibodies of binding sites on substrate molecules. Since it is the interactive capacity and nature of a protein that defines that protein's biological functional activity, certain amino acid sequence substitutions can be made in 10 a protein sequence, and, of course, its underlying DNA coding sequence, and nevertheless obtain a protein with like properties. It is thus contemplated by the inventors that various changes may be made in the peptide sequences of the disclosed compositions by making changes in the corresponding DNA sequences that encode the peptides in which the peptides shown' no appreciable loss of their biological utility or activity. 15 A further aspect of the invention comprises functional homologues, which differ in one or more amino acids from those of a polypeptide provided herein as the result of one or more conservative amino acid substitutions. It is well known in the art that one or more amino acids in a native sequence can be substituted with at least one other amino acid, the charge and polarity of which are similar to that of the native amino acid, resulting in a silent change. For instance, 20 valine is a conservative substitute for alanine and threonine is a conservative substitute for serine. Conservative substitutions for an amino acid within the native polypeptide sequence can be selected from other members of the class to which the naturally occurring amino acid belongs. Amino acids can be divided into the following four groups: (1) acidic amino acids, (2) basic amino acids, (3) neutral polar amino acids, and (4) neutral nonpolar amino acids. Representative 25 amino acids within these various groups include, but are not limited to: (1) acidic (negatively charged) amino acids such as aspartic acid and glutamic acid; (2) basic (positively charged) amino acids such as arginine, histidine, and lysine; (3) neutral polar amino acids such as glycine, serine, threonine, cysteine, tyrosine, asparagine, and glutamine; and (4) neutral nonpolar (hydrophobic) amino acids such as alanine, leucine, isoleucine, valine, proline, phenylalanine, 30 tryptophan, and methionine. Conserved substitutes for an amino acid within a native amino acid sequence can be selected from other members of the group to which the naturally occurring amino acid belongs. For example, a group of amino acids having aliphatic side chains is glycine, alanine, valine, leucine, and isoleucine; a group of amino acids having aliphatic-hydroxyl side chains is serine and threonine; a group of amino acids having amide-containing side chains is asparagine and glutamine; a group of amino acids having aromatic side chains is phenylalanine, tyrosine, and tryptophan; a group of amino acids having basic side chains is lysine, arginine, and histidine; and a group of amino acids having sulfur-containing side chains is cysteine and methionine. Naturally conservative amino acids substitution groups are: valine-leucine, valine- isoleucine, phenylalanine-tyrosine, lysine-arginine, alanine-valine, aspartic acid-glutamic acid, and asparagine-glutamine. DNA Constructs Exogenous genetic material may be transferred into a plant by the use of a DNA construct designed for such a purpose by methods that utilize Agrobacterium, particle bombardment or other methods known to those skilled in the art. Design of such a DNA construct is generally within the skill of the art (Plant Molecular Biology: A Laboratory Manual, eds. Clark, Springer, New York (1997). Examples of such plants in to which exogenous genetic material may be transferred, include, without limitation, alfalfa, Arabidopsis, barley, Brassica, broccoli, cabbage, citrus, cotton, garlic, oat, oilseed rape, onion, canola, flax, maize, an ornamental annual and ornamental perennial plant, pea, peanut, pepper, potato, rice, rye, sorghum, soybean, strawberry, sugarcane, sugar beet, tomato, wheat, poplar, pine, fir, eucalyptus, apple, lettuce, lentils, grape, banana, tea, turf grasses, sunflower, oil palm, Phaseolus, trees, shrubs, vines, etc. It is well known that agronomically important plants comprise genotypes, varieties and cultivars, and that the methods and compositions of the present invention can be tested in these plants by those of ordinary skill in the art of plant molecular biology and plant breeding. A large number of isolated DNA promoter molecules that are active as a genetic element of a transgene in plant cells have been described. These include the nopaline synthase (P-nos) promoter (Ebert et al., Proc. Natl. Acad. Sci. (U.S.A.) 84:5745-5749, 1987), the entirety of which is herein incorporated by reference), the octopine synthase (P-ocs) promoter, which are carried on tumor-inducing plasmids of Agrobacterium tumefaciens, the caulimovirus promoters, such as the cauliflower mosaic virus (CaMV) 19S promoter (Lawton et al., Plant Mol. Biol. 9:315-324, 1987), the entirety of which is herein incorporated by reference) and the CaMV 35S promoter (Odell et al., Nature 313:810-812, 1985), the entirety of which is herein incorporated by reference), the figwort mosaic vims 35S promoter (U.S. Patent No. 6,018,100, the entirety of which is herein incorporated by reference), the light-inducible promoter from the small subunit of ribulose-l,5-bis-phosphate carboxylase (ssRUBISCO), the Adh promoter (Walker et al., Proc. Natl. Acad. Sci. (U.S.A.) 84:6624-6628, 1987), the entirety of which is herein incorporated by reference), the sucrose synthase promoter (Yang et al., Proc. Natl. Acad. Sci. (U.S.A.) 87:4144- 4148, 1990), the entirety of which is herein incorporated by reference), the R gene complex promoter (Chandler et al., Plant Cell 1:1175-1183, 1989, the entirety of which is herein incorporated by reference), and the chlorophyll a/b binding protein gene promoter, etc. A variety of promoters specifically active in vegetative tissues, such as leaves, stems, roots and tubers, can be used to express the nucleic acid molecules of the present invention. Examples of tuber-specific promoters include, but are not limited to the class I and II patatin promoters (Bevan et al., EMBO J. 8: 1899-1906, 1986); Koster-Topfer et al., Mol Gen Genet 219: 390-396, 1989); Mignery et al., Gene 62:27-44, 1988); Jefferson et al., Plant Mol. Biol. 14: 995-1006, 1990), herein incorporated by reference in their entireties), the promoter for the potato tuber ADPGPP genes, both the large and small subunits; the sucrose synthase promoter (Salanoubat and Belliard, Gene 60:47-56, 1987), Salanoubat and Belliard, Gene 84:181-185, 1989), herein incorporated by reference in their entirety); and the promoter for the major tuber proteins including the 22 kd protein complexes and proteinase inhibitors (Hannapel, Plant Physiol. 101: 703-704, 1993), herein incorporated by reference in its entirety). Examples of leaf- specific promoters include but are not limited to the ribulose biphosphate carboxylase (RbcS or RuBISCO) promoters (see, e.g., Matsuoka et al., Plant J. 6:311-319, 1994), herein incorporated by reference in its entirety); the light harvesting chlorophyll a/b binding protein gene promoter (see, e.g., Shiina et al, Plant Physiol. 115:477-483, 1997; Casal et al., Plant Physiol. 116:1533- 1538,1998, herein incorporated by reference in their entireties); and the Arabidopsis thaliana myb-related gene promoter (Atmyb5) (Li et al., FEBS Lett. 379:117-121, 1996, herein incorporated by reference in its entirety). Examples of root-specific promoter include but are not limited to the promoter for the acid chitinase gene (Samac et al, Plant Mol. Biol. 25:587-596, 1994), herein incorporated by reference in its entirety); the root specific subdomains of the CaMV35S promoter that have been identified (Lam et al., Proc. Natl. Acad. Sci. (U.S.A.) 86:7890-7894, 1989, herein incorporated by reference in its entirety); the ORF13 promoter from Agrobacterium rhizogenes which exhibits high activity in roots (Hansen et al., Mol. Gen. Genet 254:337-343, 1997), herein incorporated by reference in its entirety); the promoter for the tobacco root-specific gene RB7 (US Patent 5,750,386; Yamamoto et al., Plant Cell 3:371-382, 1991, herein incorporated by reference in its entirety); and the root cell specific promoters reported by Conkling et al (Conkling et al., Plant Physiol. 93:1203-1211, 1990, herein incorporated by reference in its entirety), and the POX1 (Poxl, poxl) promoter (Hertig, et al. Plant Mol. Biol. 16:171,1991). Another class of useful vegetative tissue-specific promoters are meristematic (root tip and shoot apex) promoters. For example, the "SHOOTMERISTEMLESS" and "SCARECROW" promoters, which are active in the developing shoot or root apical meristems (Di Laurenzio et al., Cell 86:423- 433,1996; Long, Nature 379:66-69, 1996); herein incorporated by reference in their entireties), can be used. Another example of a useful promoter is that which controls the expression of 3-hydroxy-3- methylglutaryl coenzyme A reductase HMG2 gene, whose expression is restricted to meristematic and floral (secretory zone of the stigma, mature pollen grains, gynoecium vascular tissue, and fertilized ovules) tissues (see, e.g., Enjuto et al., Plant Cell. 7:517-527, 1995, herein incorporated by reference in its entirety). Also another example of a useful promoter is that which controls the expression of knl-related genes from maize and other species which show meristem-specific expression (see, e.g., Granger et al., Plant Mol. Biol. 31:373-378, 1996; Kerstetter et al., Plant Cell 6:1877-1887, 1994; Hake et al, Philos. Trans. R. Soc. Lond. B. Biol. Sci. 350:45-51, 1995, herein incorporated by reference in their entireties). Another example of a meristematic promoter is the Arabidopsis thaliana KNAT1 promoter. In the shoot apex, KNAT1 transcript is localized primarily to the shoot apical meristem; the expression of KNATI in the shoot meristem decreases during the floral transition and is restricted to the cortex of the inflorescence stem (see, e.g., Lincoln et al., Plant Cell 6:1859-1876, 1994, herein incorporated by reference in its entirety). Suitable seed-specific and seed enhanced promoters can be derived from the following genes: MAC1 from maize (Sheridan et al, Genetics 142:1009-1020, 1996, herein incorporated by reference in its entirety); Cat3 from maize (Genbank No. L05934, Abler et al, Plant Mol. Biol. 22:10131-1038, 1993, herein incorporated by reference in its entirety); vivparous-1 from Arabidopsis (Genbank No. U93215); Atimycl from Arabidopsis (Urao et al, Plant Mol. Biol. 32:571-57, 1996; Conceicao et al., Plant 5:493-505, 1994, herein incorporated by reference in their entireties); napA from Brassica rtapus (Genbank No. J02798); the napin gene family from Brassica napus (Sjodahl et al., Planta 197:264-271,1995, herein incorporated hy reference in its entirety). The ovule-specific promoter for BEL1 gene (Reiser et al. Cell 53:735-742, 1995, Genbank No. U39944; Ray et al, Proc. Natl. Acad. Sci. USA 91:5761-5765, 1994, all of which are herein incorporated by reference in their entireties) can also be used. The egg and central cell specific MEA (FIS1) and FIS2 promoters are also useful reproductive tissue-specific promoters (Luo et al., Proc. Natl. Acad. Sci. USA, 97:10637-10642, 2000; Vielle-Calzada, et al., Genes Dev. 13:2971-2982,1999; herein incorporated by reference in their entireties). A maize pollen-specific promoter has been identified in maize (Guerrero et al., Mol. Gen. Genet. 224:161-168, 1990, herein incorporated by reference in its entirety). Other genes specifically expressed in pollen have been described (see, e.g., Wakeley et al., Plant Mol. Biol. 37:187-192, 1998; Ficker et al., Mol. Gen. Genet. 257:132-142, 1998; Kulikauskas et al., Plant Mol. Biol. 34:809-814, 1997; Treacy et al., Plant Mol. Biol. 34:603-611, 1997; all of which are herein incorporated by reference in their entireties). Promoters derived from genes encoding embryonic storage proteins, which includes the gene encoding the 2S storage protein from Brassica napus (Dasgupta et al, Gene 133:301-302, 1993, herein incorporated by reference in its entirety); the 2s seed storage protein gene family from Arabidopsis-, the gene encoding oleosin 20kD from Brassica napus (GenBank No. M63985); the genes encoding oleosin A (Genbank No. U09118) and oleosin B (GenBank No. U09119) from soybean; the gene encoding oleosin from Arabidopsis (GenBank No. Z17657); the gene encoding oleosin 18kD from maize (GenBank No. J05212, Lee, Plant Mol. Biol. 26:1981-1987, 1994), herein incorporated by reference in its entirety); and the gene encoding low molecular weight sulphur rich protein from soybean (Choi et al., Mol. Gen. Genet. 246:266- 268,1995, herein incorporated by reference in its entirety), can also be used. Promoters derived from zein encoding genes (including the 15 kD, 16 kD, 19 kD, 22 kD, 27 kD, and gamma genes; Pedersen et al., Cell 29:1015-1026, 1982, herein incorporated by reference in its entirety) can be also used. The zeins are a group of storage proteins found in maize endosperm. Other promoters known to function, for example, in maize, include the promoters for the following genes: waxy, Brittle, Shrunken 2, Branching enzymes I and II, starch synthases, debranching enzymes, oleosins, glutelins, and sucrose synthases. A particularly preferred promoter for maize endosperm expression is the promoter for the glutelin gene from rice, more particularly the Osgt-1 promoter (Zheng et al., Mol. Cell Biol. 13:5829-5842, 1993, herein incorporated by reference in its entirety). Examples of promoters suitable for expression in wheat include those promoters for the ADPglucose pyrophosphorylase (ADPGPP) subunits, the granule bound and other starch synthases, the branching and debranching enzymes, the embryogenesis-abundant proteins, the gliadins, and the glutenins. Examples of such promoters in rice include those promoters for the ADPGPP subunits, the granule bound and other starch synthases, the branching enzymes, the debranching enzymes, sucrose synthases, and the glutelins. A particularly preferred promoter is the promoter for rice glutelin, Osgt-1. Examples of such promoters for barley include those for the ADPGPP subunits, the granule bound and other starch synthases, the branching enzymes, the debranching enzymes, sucrose synthases, the hordeins, the embryo globulins, and the aleurone specific proteins. A tomato promoter active during fruit ripening, senescence and abscission of leaves and, to a lesser extent, of flowers can be used (Blume et al., Plant J. 12:731-746, 1997, herein incorporated by reference in its entirety). Other exemplary promoters include the pistol specific promoter in the potato (Solanum tuberosum L.) SK2 gene, encoding a pistil-specific basic endochitinase (Ficker et al., Plant Mol. Biol. 35:425-431, 1997, herein incorporated by reference in its entirety); the Blec4 gene from pea (.Pisum sativum cv. Alaska), active in epidermal tissue of vegetative and floral shoot apices of transgenic alfalfa. This makes it a useful tool to target the expression of foreign genes to the epidermal layer of actively growing shoots. The tissue specific E8 promoter from tomato is also useful for directing gene expression in fruits (Deikman, et al., Plant Physiology 100:2013-2017,1992). It is further recognized that since in most cases the exact boundaries of regulatory sequences have not been completely defined, DNA fragments of different lengths may have identical promoter activity. Promoters that are known or are found to cause transcription of DNA in plant cells can be used in the present invention. Such promoters may be obtained from a variety of sources such as plants and plant viruses. In addition to promoters that are known to cause transcription of DNA in plant cells, other promoter molecules may be identified for use in the current invention by screening a plant cDNA library for genes that are selectively or preferably expressed in the target tissues or cells and isolating the 5' genomic region of the identified cDNAs. Constructs or vectors may also include with the coding region of interest a polynucleic acid that acts, in whole or in part, to terminate transcription of that region. For example, such sequences have been isolated including the Tr7 3' sequence and the nos 3' sequence (Ingelbrecht et al., The Plant Cell 1:671-680, 1989, the entirety of which is herein incorporated by reference; Bevan et al., Nucleic Acids Res. 11:369-385, 1983, the entirety of which is herein incorporated by reference). A vector or construct may also include regulatory elements. Examples of such include the Adh intron 1 (Callis et al, Genes and Develop. 1:1183-1200, 1987, the entirety of which is herein incorporated by reference), the sucrose synthase intron (Vasil et al, Plant Physiol. 91:1575-1579, 1989, the entirety of which is herein incorporated by reference) and the TMV omega element (Gallie et al., Plant Cell 1:301-311, 1989, the entirety of which is herein incorporated by reference). These and other regulatory elements may be included when appropriate. A vector or construct may also include a selectable marker. Selectable markers may also be used to select for plants or plant cells that contain the exogenous genetic material. Examples of such include, but are not limited to, a neo gene (Potrykus et al., Mol Gen. Genet. 199:183- 188, 1985, the entirety of which is herein incorporated by reference) which codes for kanamycin resistance and can be selected for using kanamycin, G418, etc.; a bar gene that provides for bialaphos resistance; a mutant EPSP synthase gene (Hinchee et al, Bio/Technology 6:915-922 (1988), the entirety of which is herein incorporated by reference) that provide for glyphosate resistance; a nitrilase gene that provides for resistance to bromoxynil (Stalker et al, J. Biol. Chem. 263:6310-6314 (1988), the entirety of which is herein incorporated by reference); a mutant acetolactate synthase gene (ALS) which confers imidazolinone or sulphonylurea; and a methotrexate resistant DHFR gene (Thillet et al., J. Biol. Chem. 263:12500-12508, 1988, the entirety of which is herein incorporated by reference). A vector or construct may also include a screenable marker. Screenable markers may be used to monitor expression. Exemplary screenable markers include a (^-glucuronidase or uidA gene (GUS) which encodes an enzyme for which various chromogenic substrates are known (Jefferson, Plant Mol. Biol, Rep. 5:387-405 (1987), the entirety of which is herein incorporated by reference; Jefferson et al., EMBO J. 6:3901-3907 (1987), the entirety of which is herein incorporated by reference); an R-locus gene, which encodes a product that regulates the production of anthocyanin pigments (red color) in plant tissues (Dellaporta et al., Stadler Symposium 11:263-282 (1988), the entirety of which is herein incorporated by reference); a P- lactamase gene (Sutcliffe et al., Proc. Natl. Acad. Sci. (U.SA.) 75:3737-3741 (1978), the entirety of which is herein incorporated by reference), a gene which encodes an enzyme for which various chromogenic substrates are known {e.g., PAD AC, a chromogenic cephalosporin); a luciferase gene (Ow et al., Science 234:856-859 (1986), the entirety of which is herein incorporated by reference); a xylE gene (Zukowsky et al., Proc. Natl. Acad. Sci. (U.SA.) 80:1101-1105 (1983), the entirety of which is herein incorporated by reference) which encodes a catechol dioxygenase that can convert chromogenic catechols; an a-amylase gene (Ikatu et al., Bio/Technol. 8:241-242, 1990, the entirety of which is herein incorporated by reference); a tyrosinase gene (Katz et al., J. Gen. Microbiol. 129:2703-2714, 1983, the entirety of which is herein incorporated by reference) which encodes an enzyme capable of oxidizing tyrosine to DOPA and dopaquinone which in turn condenses to melanin; and an a-galactosidase. Introduction of Polynucleotides into Plants There are many methods for introducing transforming nucleic acid molecules into plant cells. Suitable methods are believed to include virtually any method by which nucleic acid molecules may be introduced into a cell, such as by Agrobacterium infection or direct delivery of nucleic acid molecules such as, for example, by PEG-mediated transformation, by electroporation or by acceleration of DNA coated particles, etc. (Potrykus, Ann. Rev. Plant Physiol. Plant Mol. Biol. 42:205-225 (1991), the entirety of which is herein incorporated by reference; Vasil, Plant Mol. Biol. 25:925-937 (1994), the entirety of which is herein incorporated by reference). For example, electroporation has been used to transform Zea mays protoplasts (Fromm et al., Nature 312:791-793, 1986, the entirety of which is herein incorporated by reference). Other vector systems suitable for introducing transforming DNA into a host plant cell include but are not limited to binary artificial chromosome (BIBAC) vectors (Hamilton et al., Gene 200:107-116, 1997, the entirety of which is herein incorporated by reference), and transfection with RNA viral vectors (Della-Cioppa et al., Ann. N.Y. Acad. Sci. (1996), 792 pp Engineering Plants for Commercial Products and Applications, pp 57-61, the entirety of which is herein incorporated by reference. Technology for introduction of DNA into cells is well known to those of skill in the art. Four general methods for delivering a gene into cells have been described: (1) chemical methods (Graham and van der Eb, Virology 54:536-539, 1973, the entirety of which is herein incorporated by reference); (2) physical methods such as microinjection (Capecchi, Cell 22:479- 488 (1980), the entirety of which is herein incoiporated by reference), electroporation (Wong and Neumann, Biochem. Biophys. Res. Commun. 707:584-587 (1982); Fromm et al., Proc. Natl. Acad. Sci. (U.S.A.) 82:5824-5828 (1985); U.S. Patent No. 5,384,253, all of which are herein incorporated in their entirety); and the gene gun (Johnston and Tang, Methods Cell Biol. 43:353- 365 (1994), the entirety of which is herein incorporated by reference); (3) viral vectors (Clapp, Clin. Perinatal. 20:155-168, 1993; Lu et al., J. Exp. Med. 178:2089-2096, 1993; Eglitis and Anderson, Biotechniques 6:608-614, 1988, all of which are herein incorporated in their entirety); and (4) receptor-mediated mechanisms (Curiel et al., Hum. Gen. Ther. 3:147-154, 1992, Wagner et al., Proc. Natl. Acad. Sci. USA 89:6099-6103, 1992, all of which are incorporated by reference in their entirety). Acceleration methods that may be used include, for example, microprojectile bombardment and the like. One example of a method for delivering transforming nucleic acid molecules to plant cells is microprojectile bombardment This method has been reviewed by Yang and Christou, eds., Particle Bombardment Technology for Gene Transfer, Oxford Press, Oxford, England (1994), the entirety of which is herein incorporated by reference. Non- biological particles (microprojectiles) that may be coated with nucleic acids and delivered into cells by a propelling force. Exemplary particles include those comprised of tungsten, gold, platinum, and the like. Agrobacterium-medaated. transfer is a widely applicable system for introducing genes into plant cells because the DNA can be introduced into whole plant tissues, thereby bypassing the need for regeneration of an intact plant from a protoplast. The use of Agrobacterium-mediated plant integrating vectors to introduce DNA into plant cells is well known in the art. See, for example the methods described by Fraley et al., Bio/Technology 3:629-635 (1985) and Rogers et al., Methods Enzymol. 153:253-277 (1987), both of which are herein incorporated by reference in their entirety. Further, the integration of the Ti-DNA is a relatively precise process resulting in few rearrangements. The region of DNA to be transferred is defined by the border sequences, and intervening DNA is usually inserted into the plant genome as described (Spielmann et al., Mol. Gen. Genet 205:34 (1986), the entirety of which is herein incorporated by reference). A transgenic plant resulting from Agrobacterium transformation methods frequently contains a single gene on one chromosome. Such transgenic plants can be referred to as being hemizygous for the added gene. More preferred is a transgenic plant that is homozygous for the added structural gene; i.e., a transgenic plant that contains two added genes, one gene at the same locus on each chromosome of a chromosome pair. A homozygous transgenic plant can be obtained by sexually mating (selfing) an independent segregant transgenic plant that contains a single added gene, germinating some of the seed produced and analyzing the resulting plants produced for the gene of interest It is also to be understood that two different transgenic plants can also be mated to produce offspring that contain two independently segregating added, exogenous genes. Selfing of appropriate progeny can produce plants that are homozygous for both added, exogenous genes that encode a polypeptide of interest. Back-crossing to a parental plant and out-crossing with a non-transgenic plant are also contemplated, as is vegetative propagation. The regeneration, development, and cultivation of plants from single plant protoplast transformants or from various transformed explants is well known in the art (Weissbach and Weissbach, In: Methods for Plant Molecular Biology, (eds.), Academic Press, Inc. San Diego, CA, (1988), the entirety of which is herein incorporated by reference). This regeneration and growth process typically includes the steps of selection of transformed cells, culturing those individualized cells through the usual stages of embryonic development through the rooted plantlet stage. Transgenic embryos and seeds are similarly regenerated. Hie resulting transgenic rooted shoots are thereafter planted in an appropriate plant growth medium such as soil. The development or regeneration of plants containing the foreign, exogenous gene that encodes a protein of interest is well known in the art. Preferably, the regenerated plants are self- pollinated to provide homozygous transgenic plants. Otherwise, pollen obtained from the regenerated plants is crossed to seed-grown plants of agronomically important lines. Conversely, pollen from plants of these important lines is used to pollinate regenerated plants. A transgenic plant of the present invention containing a desired polypeptide is cultivated using methods well known to one skilled in the art. The present invention also provides for parts of the plants of the present invention. Plant parts, without limitation, include seed, endosperm, ovule and pollen. In a particularly preferred embodiment of the present invention, the plant part is a seed. Methods for transforming dicots, primarily by use of Agrobacterium tumefaciens, and obtaining transgenic plants have been published, e.g., cotton (U.S. Patent No. 5,004,863, U.S. Patent No. 5,159,135, U.S. Patent No. 5,518,908, all of which are herein incorporated by reference in their entirety), soybean (U.S. Patent No. 5,569,834, the entirety of which is herein incorporated by reference) and Brassica (U.S. Patent No. 5,463,174, the entirety of which is herein incorporated by reference). Transformation of monocotyledons using electroporation, particle bombardment, and Agrobacterium have also been reported. For example, transformation and plant regeneration have been achieved in asparagus, barley, Zea mays (Fromm et al., Bio/Technology 8:833 (1990), Armstrong et al., Crop Science 35:550-557 (1995), all of which are herein incorporated by reference in their entirety); oat; rice, rye, sugarcane; tall fescue and wheat (U.S. Patent No. 5,631,152, the entirety of which is herein incorporated by reference.) In addition to the above discussed procedures, practitioners are familiar with the standard resource materials which describe specific conditions and procedures for the construction, manipulation and isolation of macromolecules (e.g., DNA molecules, plasmids, etc.), generation of recombinant organisms and the screening and isolating of clones, (see for example, Sambrook et al, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press (1989); Mailga et al., Methods in Plant Molecular Biology, Cold Spring Harbor Press (1995), the entirety of which is herein incorporated by reference; Birren et al., Genome Analysis: Detecting Genes, 1, Cold Spring Harbor, New York (1998), the entirety of which is herein incorporated by reference; Birren et al, Genome Analysis: Analyzing DNA, 2, Cold Spring Harbor, New York (1998), the entirety of which is herein incorporated by reference; Plant Molecular Biology: A Laboratory Manual, eds. Clark, Springer, New York (1997), the entirety of which is herein incorporated by reference). Having now generally described the invention, the same will be more readily understood through reference to the following examples, which are provided by way of illustration, and are not intended to be limiting of the present invention, unless specified. EXAMPLES EXAMPLE 1 When an isolated native plant polynucleotide comprising a coding sequence is reconstructed as a transgene, then introduced into the plant by methods of plant transformation there is a risk that expression from the endogenous homologous plant gene will interact negatively with the transgene. To avoid these negative interactions it may be necessary to provide a transgene polynucleotide substantially divergent in sequence from the native plant gene. An artificial polynucleotide molecule can be produced by the method of the present invention and used to reduce the occurrence of transgene silencing. This example serves to illustrate methods of the present invention that result in the production of a polynucleotide encoding a modified plant EPSP synthase. The native rice (Oryzae sativa) EPSPS enzyme and chloroplast transit peptide is used to construct an artificial polynucleotide molecule that also includes codons that encode for substituted amino acids that do not naturally occur in the rice EPSPS enzyme. These substituted amino acids provide for a glyphosate resistant rice EPSPS enzyme (OsEPSPS_TIPS, SEQ ID NO: 1). The steps described in Table 6 are used to construct such an artificial polynucleotide sequence (OsEPSPS_AT, SEQ ID NO:3) using an Arabidopsis codon usage table and the parameters for construction of a substantially divergent polynucleotide molecule, which when expressed in plants encodes a modified rice EPSPS enzyme resistant to glyphosate herbicide. The comparison of the native rice EPSPS gene sequence referred to as OsEPSPS_Nat (SEQ ID NO:2) that has previously been modified to encode a glyphosate resistant enzyme to the polynucleotide molecule modified for Arabidopsis codon usage, OsEPSPS_AT (SEQ ID NO: 3) and to the sequence modified for Zea mays codon usage, OsEPSPS_ZM (SEQ ID NO: 4) by this method is shown in Figure 1. Figure 1 shows nucleotide bases changed in the modified polynucleotides compared to OsEPSPS_Nat, SEQ ID NO: 2. Table 6. Polynucleotide design for a modified rice EPSP synthase (OsEPSPS_AT) 1. Substitute amino acids at positions 173 and 177 to provide a modified rice EPSPS enzyme resistant to glyphosate herbicide shown in SEQ ID NO: 1. 2. Back translate SEQ ID NO:l to generate an artificial polynucleotide sequence using the Arabidopsis thaliana codon usage table (Table 2). 3. Perform sequence alignment with native OsEPSPS polynucleotide sequence (SEQ ID NO:2) and the artificial polynucleotide sequence to determine degree of sequence identity, map open reading frames, select patterns to search and identify restriction enzymes recognition sequences. 4. Make corrections to the codons used in the artificial polynucleotide sequence to achieve desired percentage of sequence identity and to avoid clustering of identical codons. This is especially important for amino acids that are occur at high frequency, i.e., alanine, glycine, histidine, leucine, serine, and valine. Approximate distribution of codon usage in the polynucleotide sequence according to the Arabidopsis codon usage, Table 2. 5. The polynucleotide sequence is inspected for local regions that have a GC:AT ratio higher than about 2 over a range of about 50 contiguous nucleotides. The polynucleotide sequence is adjusted as necessary, by substituting codons in these regions such that the local GC:AT ratio is less than about 2 and the entire polynucleotide composition is in the range of 0.9-1.3. 6. Introduce stop codons to translation frames "b", "c", "d", "e" and "f\ Translation stop codons are created in the "b", "c", "d", "e" and "f' translational frames by replacing one or more codons within about 130 base pairs (bps) of the ends of the artificial polynucleotide that creates a stop codon without changing the amino acid coding sequence of frame one. 7. Eliminate ATG codons from forward (frames "b" and "c") and reverse open reading frames (frame "d", "e", "f'). The forward and reverse reading frames are inspected for the presence of ATG codons. Any ATG codons in frame "b" and "c" found in the polynucleotide sequence before third Met in frame "a" of the polynucleotide are eliminated by replacing one or more codons that overlap the ATG changing one of the nucleotides without changing the amino acid coding sequence of frame "a". In the reverse frames, replacement of ATG or stop codon introduction may be done to interrupt potential reading frames. 8. Eliminate unwanted restriction enzyme recognition patterns and other specific patterns (polyadenylation, RNA splicing, sequence instability patterns). The polynucleotide sequence is inspected for the presence of any unwanted polynucleotide patterns and the patterns are disrupted by substituting codons in these regions. 9. Check sequence identity between a first polynucleotide and the artificial polynucleotide created by the method of the present invention. Eliminate sequence identity in a contiguous polynucleotide that is longer than 23 bps. It is desirable to eliminate sequence identity greater than about 15 bps. It is helpful to select from amino acids such as, serine, arginine, and leucine that have 6 codons or from amino acids with 4 codons to eliminate sequence identity. 10. Review the artificial polynucleotide sequence resulting from anyone of steps 1 to 9 for any of the sequence features identified in steps 4-9, and if the sequence does not comply with conditions make additional codon substitutions to the sequence until the conditions of steps 4-9 are met 11. Construct the artificial polynucleotide molecule by methods known in the art, e.g., using PCR with a mixture of overlapping primers. The primers at the ends of the gene may contain convenient restriction sites to allow easy cloning of the gene to selected vector. At the 5' end usually Alfm, BspHI, Ncol, Ndel, Pcil, or SphI are most convenient in as much as their sequence contains an ATG start codon, however other enzymes can be used as well if a modified polynucleotide is designed to create a fusion with another polynucleotide segment, e.g., chloroplast transit peptide and EPSPS coding sequence. 12. Perform a DNA sequence analysis of the artificial polynucleotide to confirm the synthetic construction resulted in the desired polynucleotide molecule. If errors are found, then eliminate these by site directed mutagenesis for which many methods are known to those skilled in the art of DNA mutagenesis. A Zea mays codon usage (Zea mays, Table 3) version of the glyphosate resistant rice EPSPS enzyme sequence (Oryzae sativa EPSPS enzyme with TIPS mutations, SEQ ED NO:l) is made. The polynucleotide that encodes this enzyme includes codons that encode for substituted amino acids that do not naturally occur in the native rice EPSPS enzyme. These substituted amino acids provide for a glyphosate resistant rice EPSPS enzyme. The steps described in Table 7 are used to construct a modified artificial polynucleotide sequence (OsEPSPSZM, SEQ ID NO:4) based on a Zea mays codon usage table that encodes a modified rice EPSPS enzyme resistant to glyphosate herbicide. The comparison of the OsEPSPS Nat polynucleotide sequence (SEQ ID NO:2) to the OsEPSPS_ZM artificial polynucleotide sequence (SEQ ID NO:4) using the Zea mays codon usage is shown in Figure 2. Table 7. Polynucleotide construction for modified rice EPSP synthase (OsEPSPS_ZM) 1. Back translate SEQ ID NO:l to generate an artificial polynucleotide sequence using the Zea mays codon usage table (Table 3). 2. Perform sequence alignment with the native OsEPSPS polynucleotide sequence (SEQ ID NO:2) and the artificial polynucleotide sequence to determine degree of sequence identity, map open reading frames, select patterns to search and identify restriction enzymes recognition sequences. 3. Make corrections to the codons used in the artificial polynucleotide sequence to achieve desired percentage of sequence identity and to avoid clustering of identical codons. This is especially important for amino acids that are occur at high frequency, i.e., alanine, glycine, histidine, leucine, serine, and valine. Approximate distribution of codon usage in the polynucleotide sequence according to the Zea mays codon usage, Table 3. 4. The polynucleotide sequence is inspected for local regions that have a GC:AT ratio higher than about 2 over a range of about 50 contiguous nucleotides. The polynucleotide sequence is adjusted as necessary, by substituting codons in these regions such that the local GC:AT ratio is less than about 2 and the entire polynucleotide composition is in the range of 1.2-1.7. 5. Follow steps 6-12 of Table 6. Table 8. Sequence percent identity between OsEPSPS polynucleotides. OsEPSPSZM OsEPSPS_AT OsEPSPS_Nat OsEPSPS_ZM 100.00 73.51 71.58 OsEPSPS_AT 100.00 74.03 OsEPSPS_Nat 100.00 Table 9. The nucleotide composition and GC:AT ratio of the modified polynucleotide sequences for the rice EPSPS gene sequence. A G 444 470 C 336 381 OsEPSPS_AT 377 OsEPSPS ZM 365 T GC:AT 391 1.02 332 1.22 The two rice EPSPS artificial polynucleotide sequences (SEQ ID NO:3 and SEQ ID NO:4) are modified such that the percent identity is below 75 percent compared to SEQ ID NO:2 or relative to each other (Table 8). The nucleotide composition and GC:AT ratio of the polynucleotide sequences for the rice EPSPS gene sequence are shown in Table 9. These polynucleotides can be selected for use in plant expression constructs together with different regulatory elements or they can be combined in a single plant by retransformation with a DNA construct or by methods of plant breeding. Concerns with gene silencing and recombination are reduced when DNA constructs have reduced levels of homologous DNA. EXAMPLE 2 Corn (Zea mays) has been genetically modified to have resistance to glyphosate herbicide (US Patent No. 6,040,497). These corn plants contain a transgene with a corn EPSP synthase modified for glyphosate tolerance. The methods of the present invention can be used to construct a new artificial polynucleotide encoding a corn EPSP synthase that is substantially different in percent identity to the endogenous corn EPSP synthase gene. The newly constructed corn EPSP synthase artificial polynucleotide can be used as a selectable marker during the selection of transgenic plant lines that may contain additional transgenic agronomic traits. During hybrid corn seed production, it is useful to have both parents glyphosate tolerant using non-interfering transgenes. Table 10. Polynucleotide construction for modified corn EPSP synthase (ZmEPSPS_ZM, SEQ ID NO: 10) 1. Back translate SEQ ID NO:8 to generate a polynucleotide sequence using the Zea mays codon usage table (Table 3). 2. Perform sequence alignment with ZmEPSPS_Nat polynucleotide sequence (SEQ ID NO:9) and the artificial polynucleotide sequence to determine degree of sequence identity, map open reading frames, select patterns to search and identify restriction enzymes recognition sequences. 3. Make corrections to the codons used in the artificial polynucleotide sequence to achieve desired percentage of sequence identity and to avoid clustering of identical codons. This is especially important for amino acids that are occur at high frequency, i.e., alanine, glycine, histidine, leucine, serine, and valine. Approximate distribution of codon usage in the polynucleotide sequence according to the Zea mays codon usage, Table 3. 4. The artificial polynucleotide sequence is inspected for local regions that have a GC:AT ratio higher than about 2 over a range of about 50 contiguous nucleotides. The polynucleotide sequence is adjusted as necessary, by substituting codons in these regions such that the local GC:AT ratio is less than about 2 and the entire polynucleotide composition is in the range of 1.2-1.7. 5. Follow steps 6-12 of Table 6. Table 11. Sequence percent identity between ZmEPSPS polynucleotides. ZmEPSPSZM ZmEPSPS_Nat ZmEPSPS_ZM 100.00 74.81 ZmEPSPS_Nat 100.00 Maize EPSPS gene nucleotide sequence is also modified to reduce identity between synthetic and native gene and maintain overall GC:AT ratio typical for monocots. The GC:AT ratio for the ZmEPSPS_ZM sequence is 1.38. The sequence identity is reduced to about 75% between native (ZmEPSPS_Nat, SEQ ID NO:9) and synthetic (ZmEPSPS_ZM, SEQ ID NO: 10). The comparison of native polynucleotides encoding EPSPS indicate that the chloroplast transit peptide is the most divergent fragment of the gene. Similarity in nucleotide sequence of mature peptides is higher than 88% for maize and rice enzymes, and some conserved regions have sequence identity as long as 50 bps. Posttranscriptional gene silencing has been observed for sequences as small as 60 polynucleotides (Sijen et al., Plant Cell, 8:2277-2294, 1996; Mains, Plant Mol. Biol. 43:261-273,2000). EXAMPLE 3 Soybean (Glycine max) has been genetically modified to be tolerant to glyphosate by expression of a class II EPSPS isolated from Agrobacterium (Padgette et al. Crop Sci. 35:1451- 1461, 1995). A soybean native EPSPS gene sequence has been identified and an artificial polynucleotide sequence designed using the method of the present invention. The artificial polynucleotide encodes a protein sequence that is modified to produce a glyphosate resistant EPSPS enzyme (GmEPSPSJKS, SEQ ID NO:5) by replacing ammo acids T to I, R to K and P to S within the GNAGTAMRP motif, resulting in a modified soybean EPSPS enzyme with the motif GNAGIAMKS (SEQ ED NO:34), also referred to as IKS mutant. Expression of a modified EPSPS enzyme in the cells of a plant by transformation with a transgene plant expression cassette, which contains a polynucleotide encoding the modified EPSPS with the motif GNAGIAMKS will confer glyphosate tolerance to the plants. Additional amino acid substitutions for the arginine (R) in the motif can also include asparagine (N). Table 12. Polynucleotide construction for modified soybean EPSP synthase gene (GmEPSPS_GM, SEQ ID NO:7). 1. Back translate SEQ ID NO:5 to generate an artificial polynucleotide sequence using the Glycine max codon usage table (Table 4). 2. Perform sequence alignment with GmEPSPS Nat polynucleotide sequence (SEQ ID NO:6) and the artificial polynucleotide sequence to determine degree of sequence identity, map open reading frames, select patterns to search and identify restriction enzymes recognition sequences. 3. Make corrections to the codons used in the artificial polynucleotide sequence to achieve desired percentage of sequence identity and to avoid clustering of identical codons. This is especially important for amino acids that are occur at high frequency, i.e., alanine, glycine, histidine, leucine, serine, and valine. Approximate distribution of codon usage in the polynucleotide sequence according to the Glycine max codon usage, Table 4. 4. The polynucleotide sequence is inspected for local regions that have a GC:AT ratio higher than about 2 over a range of about 50 contiguous nucleotides. The polynucleotide sequence is adjusted as necessary, by substituting codons in these regions such that the local GC:AT ratio is less than about 2 and the entire polynucleotide composition is in the range of 0.9-1.3. Follow steps 6-12 of Table 6. Table 13. Comparison of the sequence percent identity of the modified GmEPSPS at GmEPSPS_GM GmEPSPS_Nat GmEPSPS_GM 100.00 72.43 GmEPSPS_Nat 100.00 The soybean native EPSPS gene is modified using a soybean codon table (Table 4) and the conditions of the method of the present invention. The relative ratio of GC:AT is not changed in the modified gene, however the sequence identity between the two is reduced to 72%. EXAMPLE 4 The native ccroA polynucleotide gene isolated from Agrobacterium strain CP4 (U.S. Patent No. 5,633,435, herein incorporated by reference in its entirety) that encodes a glyphosate resistant EPSP synthase (SEQ ID NO: 15) can be modified by the method of the present invention to provide a polynucleotide that has the codon usage of Arabidopsis, Zea mays, or Glycine max. For the appropriate expression of CP4EPSPS to confer glyphosate tolerance in plants, a chloroplast transit peptide is necessarily fused to the CP4EPSPS coding sequence to target accumulation of the enzyme to the chloroplasts. The CTP2 chloroplast transit peptide is commonly used for the expression of this gene in transgenic plants (Nida et al., J. Agric, Food Chem. 44:1960-1966, 1996). The sequence of CP4EPSPS together with CTP2 polynucleotide (SEQ ID NO:l 1) have been modified by the method of the present invention. Other chloroplast transit peptides known in the art can be fused to the CP4EPSPS to direct the enzyme to the chloroplasts. Table 14. Polynucleotide construction for aroA:CP4 EPSP synthase coding sequence (CP4EPSPS_AT, CP4EPSPS_ZM, or CP4EPSPS_GM) 1. Place CTP2 transit peptide sequence (SEQ ID NO: 11) in front of CP4EPSPS (SEQ ID NO: 15) as a fusion polypeptide. Back translate the fusion polypeptide to produce an artificial polynucleotide sequence using the Arabidopsis thaliana codon usage table (Table 2), or the Zea mays codon usage table (Table 3), or the Glycine max codon usage table (Table 4). 2. Perform sequence alignment with native CTP2 (SEQ ID NO: 12) and native CP4EPSPS polynucleotide sequence(SEQ ID NO: 16) and the artificial polynucleotide sequence to determine degree of sequence identity, map open reading frames, select patterns to search and identify restriction enzymes recognition sequences. 3. Make corrections to the codons used in the artificial polynucleotide sequence to achieve desired percentage of sequence identity and to avoid clustering of identical codons. This is especially important for amino acids that are occur at high frequency, i.e., alanine, glycine, histidine, leucine, serine, and valine. Approximate distribution of codon usage in the polynucleotide sequence according to the Arabidopsis thaliana codon usage, Table 2, or the Zea mays codon usage table (Table 3) depending on the table in use. 4. The artificial polynucleotide sequence is inspected for local regions that have a GC:AT ratio higher than about 2 over a range of about 50 contiguous nucleotides. The polynucleotide sequence is adjusted as necessary, by substituting codons in these regions such that the local GC:AT ratio is less than about 2 and the entire polynucleotide composition is in the range of 0.9-1.3 is Table 2 is used and 1.2-1.7 if Table 3 is used. 5. Follow steps 6-12 of Table 6. Table 15. Comparison of the sequence percent identity of the artificial CP4EPSPS polynucleotides. CTP2CP CTP2CP4 CTP2CP4 CTP2CP4 CTP2CP4 GM AT ZM Syn NAT CTP2CP4 GM 100.00 75.66 74.12 75.15 74.37 CTP2CP4 AT 100.00 76.13 74.56* 72.93 CTP2CP4 ZM 100.00 77.76* 82.58 CTP2CP4 Syn 100.00 82.70 CTP2CP4 NAT 100.00 *Percent o: identity relates to the CP4EPSPS and do not include transit peptide. Table 16. The nucleotide composition and GC:AT ratio of the artificial polynucleotide sequences for the CP4EPSPS gene sequence. A C G T GC:AT CTP2CP4 GM 382 375 442 397 1.05 CTP2CP4 AT 369 408 469 350 1.22 CTP2CP4 ZM 312 487 577 290 1.65 The polynucleotide sequence CTP2_Nat (SEQ ID NO: 12) plus CP4EPSPS_Nat (SEQ ID NO: 16) designated as CTP2CP4_Nat is compared in Table 15 to the artificial polynucleotide sequences designated as CTP2CP4_AT (CTP2_AT, SEQ ID NO: 13 fused to CP4EPSPS_AT, SEQ ID NO: 17) and CTP2CP4_ZM (CTP2_AT, SEQID NO:14 fused to CP4EPSPS_ZM, SEQ ID NO: 18) produced by the method of the present invention. The polynucleotide sequence that is the most divergent from the native sequence CTP2CP4_NAT and CTP2CP4EPSPS_Syn is CTP2CP4_AT having about 73% and 75% sequence identity, respectively. The CTP2CP4_ZM polynucleotide sequence compared to CTP2CP4_Nat and CP4EPSPS_Syn has about 83% and 78% identity to these two sequences, respectively. A primary criteria for the selection of transgenes to combine in a plant is the percent identity. Table 15 can be used to select a CP4EPSPS polynucleotide molecule for plant expression cassette construction when it is known that the recipient plant will contain more than one CP4EPSPS polynucleotide. The GC:AT ratio in native CP4EPSPS is about 1.7. The artificial version with the Zea mays codon bias is produced to have a very similar GC:AT ratio. In the Arabidopsis codon version, the GC:AT ratio is decreased to about 1.2. Gene expression is also a criteria for selection of transgenes to be expressed. Expression of a transgene can vary in different crop plants, therefore having several artificial polynucleotide coding sequence available for testing in different crop plants and genotypes, varieties or cultivars is an advantage and an aspect of the invention. EXAMPLE 5 The bar polynucleotide sequence (SEQ ID N0:20) encoding a phosphinothricin acetyl transferase protein (SEQ ID NO: 19) has been used to genetically modify plants for resistance to glufosinate herbicide. Two new bar polynucleotide sequences have been designed using the method of the present invention. The alignment of BARl Nat with the two new artificial BAR1 polynucleotides is shown in Figure. 4. Table 17. Polynucleotide gene construction for BAR1_AT (SEQ ID NO:21) and BAR1_ZM (SEQ ID NO:22) 1. Back translate SEQ ID NO: 19 to generate a polynucleotide sequence using the Arabidopsis thaliana codon usage table (Table 2) or the Zea mays codon usage table (Table 3) 2. Perform sequence alignment with native BARl_Nat polynucleotide sequence (SEQ ID N0:20) and the artificial polynucleotide sequence to determine degree of sequence identity, map open reading frames, select patterns to search and identify restriction enzymes recognition sequences. 3. Make corrections to the codons used in the artificial polynucleotide sequence to achieve desired percentage of sequence identity and to avoid clustering of identical codons. This is especially important for amino acids that are occur at high frequency, i.e., alanine, glycine, histidine, leucine, serine, and valine. Approximate distribution of codon usage in the polynucleotide sequence according to the Arabidopsis thaliana codon usage, Table 2, or the Zea mays codon usage table (Table 3) depending on the table in use. 4. The artificial polynucleotide sequence is inspected for local regions that have a GC:AT ratio higher than about 2 over a range of about 50 contiguous nucleotides. The polynucleotide sequence is adjusted as necessary, by substituting codons in these regions such that the local GC:AT ratio is less than about 2 and the entire polynucleotide composition is in the range of 0.9-1.3 if Table 2 is used and 1.2-1.7 if Table 3 is used. 5. Follow steps 6-12 of Table 6. The sequence identity of artificial BAR polynucleotides is the range of 73-77% (Table 18). The native polynucleotide is highly GC rich . The artificial version (BAR1_ZM) with Zea mays codon bias has reduced the GC:AT ratio to about 1.3 and artificial version (BAR1AT) with Arabidopsis codon bias the ratio is about 1.0 (Table 19). Table 18. Sequence percent identity between bar genes at the polynucleotide sequence level. BAR1_ZM BAR1_AT BARl_Nat BAR1 ZM 100.00 77.35 76.99 BAR1AT 100.00 73.73 BAR1 Nat 100.00 Table 19. The nucleotide composition and GC:AT ratio of the artificial polynucleotide sequences for the bar gene sequence. BAR AT 139 130 144 139 1.01 BAR ZM 122 156 154 120 1.28 EXAMPLE 6 This example serves to illustrate DNA constructs for the expression of the artificial polynucleotides of the present invention in plants. A transgene DNA plant expression cassette comprises regulatory elements that control the transcription of a mRNA from the cassette. A plant expression cassette is constructed to include a promoter that functions in plants that is operably linked to a 5' leader region that is operably linked to a DNA sequence of interest operably linked to a 3' termination region. These cassettes are constructed in plasmid vectors, which can then be transferred into plants by Agrobacterium mediated transformation methods or other methods known to those skilled in the art of plant transformation. The following plasmid vector constructs are illustrated to provide examples of plasmids containing plant expression cassettes comprising the artificial polynucleotide molecules of the present invention and are not limited to these examples. The artificial polynucleotide molecules of the present invention, for example, CP4EPSPS_AT and CP4EPSPS ZM are synthesized using overlapping primers. The full length product is then amplified with gene specific primers containing overhangs with SphI (forward primer) and EcoRI (reverse primer). Genes are cloned into the vector pCRH-TOPO (Invitrogen, CA). The resulting plasmids pMON54949 (CP4EPSPS_AT, Figure 6) and pMON54950 (CP4EPSPSJZM, Figure 7) contain the artificial polynucleotide and these polynucleotides are sequenced using DNA sequencing methods to confirm that the modifications designed by the method of the present invention are contained in the artificial polynucleotides. In the next step, the artificial polynucleotide encoding the CTP2 chloroplast transit peptide is ligated to the 5' end of the CP4EPSPS polynucleotides. The CaMV 35S promoter with a duplicated enhancer (P- CaMVe35S) and a rice actin 1 intron (I-OsActl) derived from pMON3()151 (Figure 8) by digestion with SphI and Hindm ligated to the CTP2CP4EPSPS polynucleotides to create plasmids pMC)N59302 (CTP2CP4EPSPS_AT, Figure 9) and pMON59307 (CTP2CP4EPSPS_ZM, Figure 10). For the expression of the new artificial polynucleotides in monocot plants, genes are placed in plant expression cassettes containing at the 5'end of the polynucleotide, a promoter and an intron, a 5' untranslated region, and at the 3' end of the polynucleotide a transcription termination signal. For this purpose, pMON42411 (Figure 11) containing P-CaMV35S:en, I- HSP70, CTP2CP4_Nat and NOS 3' are digested with Ncol and EcoRI restriction enzymes. The pMC>N59302 (Figure 9) and pMC>N59307 (Figure 10) are digested with same restriction enzymes. Fragments are gel purified using Qiagen gel purification kit and ligated to form pMON58400 (CP4EPSPS_AT, Figure 12) and pMON58401 (CP4EPSPS_ZM, Figure 13). Additional vector pMON54964 (Figure 14), containing P-OsActl/ I-OsActl is made by replacing P-e35S/I-Hsp70 from pMON58400 (Figure 12) using Hindm /Ncol fragment from pMON25455 (Figure 15). To create a monocot expression vector containing the P-FMV promoter, pMON30152 (Figure 16) is digested with Nhel, the ends are blunted with T4DNA polymerase in the presence of 4 dNTP-s (200 fiM) and Ncol. The CPT2CP4_AT or CTP2CP4_ZM DNA fragments are isolated from pMON59302 (Figure 9) or pMON59307 (Figure 10), respectively by digesting with EcoRI, blunting with T4 DNA polymerase and Ncol digest. Gel purified DNA fragments are ligated and new plasmids pMON54992 (CTP2CP4_AT, Figure 17) and pMON54985 (CTP2CP4_ZM, Figure 18) are created. In each case the successful plasmid construction is confirmed by restriction endonuclease digestion, using among others Clal (introduced to both artificial polynucleotides) and Pst I (introduced to CP4EPSPS ZM). The CP4EPSPS_Nat present in parental vectors has both Clal and two PstI restriction sites in coding region in different location than in artificial polynucleotides. For the expression of the artificial CP4EPSPS polynucleotides in dicot plants, two parental vectors are used: pMON20999 (P-FMV/CTP2CP4_Syn/3'E-9, Figure 19) and pMON45313 (P-e35S/CTP2CP4_Syn/3'E9, Figure 20). In each plasmid, a DNA fragment containing the CTP2CP4_Syn polynucleotide is replaced with CTP2CP4_AT or CTP2CP4ZM. To create pMON59308 (P-CaMVe35S/CTP2CP4_AT, Figure 21) or pMON59309 (P- CaMVe3 5 S/CTP2CP4_ZM, Figure 22), pMON45313 is digested with Ncol and EcoRI and the DNA restriction fragments derived from NcoI/EcoRI digest of pMON59302 (CTP2CP4_AT, Figure 9) or pMON59307 (CTP2CP4_ZM, Figure 10) are ligated, respectively. To create pMON59313 (P-FMV/CTP2CP4_AT/3'E9, Figure 23) and pMON59396 (P- FMV/CTP2CP4_ZM/3'E9, Figure 24) parental plasmid pMQN20999 is digested with Ncol and BamHI to remove CTP2CP4_Syn and the restriction fragments NcoI/BamHI derived from pMON59308 (CTP2CP4_AT, Figure 21) or pM()N59309 (CTP2CP4_ZM, Figure 22) are ligated, respectively. s EXAMPLE 7 The artificial polynucleotides are tested to determine efficacy for conferring glyphosate tolerance to transgenic plants. Five different expression cassettes (Table 20) with the new artificial CP4EPSPS polynucleotides are transformed into corn and the resulting transgenic corn plants compared to the commercial standard (Roundup Ready® Corn 603, Monsanto Co.). The 10 plasmid pMON25496 (Figure 25) contained in die commercial standard has two copies of the CP4EPSPS_Nat polynucleotide, the expression driven by the P-CaMVe35S (P-CaMVe35S) and P-OsActl promoters, respectively. The plasmids containing the new artificial CP4EPSPS polynucleotides contain only a single copy of the polynucleotide to be tested. The expression of these polynucleotides are driven by the P-CaMVe35S promoter with the heat shock protein is intron I-Hsp70 or the P-FMV promoter with a rice sucrose synthase intron (I-OsSS). Plasmid pMON54964 contains rice actin 1 promoter with first native intron (U.S. Patent No. 5,641,876, herein incorporated by reference in its entirety). These plasmids are transformed into corn cells by an Agrobacterium mediated method and transgenic com lines regenerated on glyphosate selection. Transgenic corn plants can be 20 produced by an Agrobacterium mediated transformation method. A disarmed Agrobacterium strain C58 (ABI) harboring a binary construct of the present invention is used. This is transferred into Agrobacterium by a triparental mating method (Ditta et alProc. Natl. Acad. Sci. 77:7347-7351). Liquid cultures of Agrobacterium are initiated from glycerol stocks or from a freshly streaked plate and grown overnight at 26°C-28°C with shaking (approximately 150 25 rpm) to mid-log growth phase in liquid LB medium, pH 7.0 containing the appropriate antibiotics. The Agrobacterium cells are resuspended in the inoculation medium (liquid CM4C) and the density is adjusted to OD660 of 1. Freshly isolated Type II immature HiIIxLH198 and Hill corn embryos are inoculated with Agrobacterium containing a construct and co-cultured several days in the dark at 23 °C. The embryos are then transferred to delay media and incubated 30 at 28 °C for several or more days. All subsequent cultures are kept at this temperature. The embryos are transferred to a first selection medium containing carbenicillin 500/0.5 raM glyphosate). Two weeks later, surviving tissue are transferred to a second selection medium containing carbenicillin' 500/1.0 mM glyphosate). Subculture surviving callus every 2 weeks until events can be identified. This may take about 3 subcultures on 1.0 mM glyphosate. Once events are identified, bulk up the tissue to regenerate. The plantlets are transferred to MSOD media in culture vessel and kept for two weeks. Then the plants with roots are transferred into soil. Those skilled in the art of corn transformation can modify this method to provide substantially identical transgenic corn plants containing the DNA compositions of the present invention. About 30 transgenic corn lines for each plasmid construct are tested, and the transformation efficiency and expression levels of the CP4EPSPS enzyme are shown in Table 20. The transgenic corn lines are treated with glyphosate at a rate of 64oz/acre as young plants, the surviving plants are assayed by CP4EPSPS ELISA (Padgette et al. Crop Sci. 35:1451-1461, 1995) to determine the CP4 EPSPS protein expression levels (CP4 exp %) shown in Table 20, and the level of expression is compared to the commercially available standard glyphosate tolerant corn plant (Roundup Ready® corn 603, Monsanto Co., St. Louis, MO) as a percent of the amount of protein expression determined in the commercial standard. Generally, more than 50% of corn lines survive the spray with 64oz/acre glyphosate. The surviving plants are shown to have high level of CP4EPSPS expression that ranges from about 75 to 86% of commercial standard 603. Table 20. Transformation efficiency (TE), CP4 expression (average %) derived from transformation of different CP4-alt constructs. pMON Promoter/Intron # TE (%) CP4 exp (%)* 58400 (CP4 AT) P-CaMV e3 5 S/IHsp70 5.4 75.5 58401 (CP4 ZM) P-CaMV e35S/IHsp70 7.2 84.7 54964 (CP4 AT) P-OsActl 8.2 78.1 54985 (CP4 ZM) P-FMV/IOsSS 11.5 85.7 54992 (CP4 AT) P-FMV/IOsSS 11.5 78.2 nk603 (control) P-OsActl/P-e35S: - 100 * CP4EPSPS expression is calculated as percent of control (603) done on plants that survived glyphosate spray (64oz/acre). EXAMPLE 8 Three plasmid constructs are evaluated in transgenic cotton plants (Table 21). The control construct (pMC>N20999) contains P-FMV/CP4EPSPS_Syn this expression cassette is contained in the commercially available glyphosate tolerant cotton line 1445 (Roundup Ready® cotton, 5 Monsanto Co., St. Louis, MO). The plasmid constructs, pMON59313 and pMON59396 containing the CP4EPSPS_AT and CP4EPSPS_ZM polynucleotides, respectively, are assayed for transformation efficiency and CP4EPSPS en2yme levels relative to the commercial glyphosate tolerant expression cassette. About fifty transgenic cotton lines are evaluated for each construct. The artificial CP4EPSPS_AT polynucleotide driven by the P-FMV promoter 10 gives a higher percentage of plants with a single insert, and an increase in expression level of the CP4EPSPS enzyme relative to the pMON20999 expression cassette as measured by ELISA. Table 21. Transformation efficiency (TE), average CP4EPSPS expression in R0 cotton lines derived from transformation of different CP4EPSPS constructs. pMON Promoter TE (%) CP4 Exp (%) 20999 (CP4EPSPS _Syn) P-FMV 15.0 100.0 59313 (CP4EPSPS AT) P-FMV 15.0 116.4 59396 (CP4EPSPS ZM) P-FMV 16.1 52.0 EXAMPLE 9 Constructs containing the artificial CP4EPSPS polynucleotides, CP4EPSPS_AT and CP4EPSPS_ZM are evaluated in soybean (Table 22). The plasmid constructs all contain the P- 20 FMV promoter to drive expression of the new CP4EPSPS polynucleotides and are compared to the P-FMV/CP4EPSPS_Syn contained in pMON20999. About 25 to 30 transgenic soybean plants are produced for each construct. TTie transformation efficiency and CP4EPSPS enzyme levels are measured. A surprizingly high expression level of CP4EPSPS protein is measured in soybean plants containing the CP4EPSPS_ZM coding sequence (Table 22). 25 Table 22. Transformation efficiency (TE), average CP4 expression derived from transformation of different CP4EPSPS constructs. pMON Promoter TE (%) CP4Exp(%) 20999 (CP4 Syn) P-FMV 0.55 100.0 59313 (CP4_AT) P-FMV 0.40 66.6 54996 (CP4_ZM) P-FMV 0.29 242.5 EXAMPLE 10 Tobacco cells are transformed with three plasmid constructs containing different 5 CP4EPSPS polynucleotide sequences and regenerated into plants. About twenty transgenic lines are evaluated from each construct. Expression from each of the CP4EPSPS polynucleotides is driven by the P-CaMVe35S duplicated enhancer promoter (Table 23). The transformation efficiency and CP4EPSPS enzyme expression level is measured. The different CP4EPSPS polynucleotide constructs are shown to perform about the same in transgenic tobacco for 10 transformation efficiency and expression. Table 23. Transformation efficiency (TE), average CP4 expression in R0 tobacco lines derived from transformation of different CP4 EPSPS constructs. pMON Promoter TE (%) CP4 exp. (%) 59308 CP4EPSPS AT P-CaMVe35S 35 100.0 59309 CP4EPSPS ZM P-CaMVe35S 35 91.0 54313 CP4EPSPS Syn P-CaMVe35S 35 100.0 is EXAMPLE 11 Arabidopsis thaliana is transformed with four plasmid constructs by vacuum infiltration (Bechtold N, et al., CR Acad Sci Paris Sciences di la vie/life sciences 316: 1194-1199, (1993) and VI progeny evaluated to compare efficacy of the different CP4EPSPS polynucleotide 20 sequences and different promoters for the use in selection of plants on glyphosate (Table 24). About 30 transgenic VI plants (+) are produced for each construct. The constructs driven by P- CaMVe35S with the duplicated enhancer (pMON45313, pMON59308, and pMON59309) show no substantial difference in the level of expression in leaves as determined by ELISA. The plants are transformed with pMON26140 that contains CP4EPSPS_Syn driven by the P-FMV 25 promoter, these plants show the highest expression level, the expression levels detected from the plants of the test constructs are compared to pMON2614Q. Table 24. Evaluation of different CP4 expression cassettes in Arabidopsis pMON Promoter/ Plants produced CP4 exp.(%) 45313(CPEPSPS4 Syn) P-CaMVe35S + 82.1 59308(CP4EPSPS AT) P-CaMVe35S + 79.3 59309(CP4EPSPS ZM) P-CaMVe35S + 77.3 26140(CP4EPSPS_Syn) P-FMV + 100.0 EXAMPLE 12 Wheat plants transformed with the new CP4EPSPS polynucleotides are compared for transformation efficiency and CP4EPSPS enzyme expression determined by ELISA (Table 25). The CP4EPSPS ZM provides at least seven times higher CPEPSPS enzyme expression than CP4EPSPS_AT. The average expression of CP4EPSPS in leaves from wheat plants containing the CP4EPSPS_ZM polynucleotide is about 64% of that found in glyphosate resistant wheat that contains a double cassette construct, pMC)N30139: P-e35S/I-Hsp70/CP4EPSPS_Nat and P- OsActl/I-OsActl/CP4EPSPS_Nat (W0/0022704). Table 25 . Performance of dif ferent CP4EPSPS polynuc eotides in wheat pMON Promoter/Intron TE (%) CP4 Exp. (%) 58400 CP4EPSPS AT P-e35S/I-Hsp70 0.25 9.2 58401 CP4EPSPS ZM P-e35S/I-Hsp70 0.35 64.0 30139 CP4EPSPS Nat P-e35S:P-OsActl - 100.0 EXAMPLE 13 This example serves to illustrate detection of different artificial polynucleotides in transgenic plants, specifically CP4EPSPS_AT and CP4EPSPS_ZM. The other artificial polynucleotides, OsEPSPS_AT, OsEPSPS_ZM, GmEPSPS_GM, ZmEPSPS_ZM, Cn>2_AT, CTP2_ZM, Barl_AT and Barl ZM can all be specifically detected in transgenic plants by methods that provide a DNA amplicon or by hybridization of a DNA probe to a plant sample. Those skilled in the art of DNA detection can easily design primer molecules from the artificial polynucleotide sequences provided in the present invention to enable a method that will specifically detect the artificial polynucleotide in a plant sample. The use of a method or a kit that provides DNA primers or probes homologous or complementary to the artificial polynucleotides disclosed herein is an aspect of the present invention. A DNA detection method (polymerase chain reaction, PCR) is designed to detect the artificial CP4EPSPS polynucleotides in transgenic plants. The unique sets of DNA primers shown in Table 26 are designed to amplify a specific CP4EPSPS polynucleotide and to provide distinctly sized amplicons. The amplicons differ sufficiently in polynucleotide length among the various CP4EPSPS polynucleotides to make easy separation of the amplicons by standard agarose gel electrophoresis. The presence of more than one of the artificial polynucleotides can be detected in a plant by using a multiplex PCR method. Table 26. Sequence of primers used for detection of different CP4 genes in transgenic plants. Primer pair: Gene specificity PCR product (bps) SEQ ID NOs: 24 and 25 CP4EPSPS_AT 938 (940) SEQIDNOs: 26 and 27 CP4EPSPS_ZM 595 (600) SEQ ID NOs: 28 and 29 CP4EPSPS_Nat 712 (710) SEQ ID NOs: 30 and 31 CP4EPSPS_Syn 443 (440) DNA primer pairs (Table 26) are used to produce an amplicon diagnostic for a specified CP4EPSPS polynucleotide contained in a transgenic plant These primer pairs include, but are not limited to SEQ ID NO:24 and SEQ ID NO:25 for the CP4EPSPS_AT polynucleotide; SEQ ID NO:26 and SEQ ID NO:27 for the CP4EPSPS_ZM; SEQ ID NO:28 and SEQ ID NO:29 for CP4EPSPS_Nat and SEQ ID N0:30 and SEQ ID NO:31 CP4EPSPS_Syn polynucleotide molecule. In addition to these primer pairs, any primer pair derived from SEQ ID NO: 17 or SEQ ID NO: 18 that when used in a DNA amplification reaction produces a DNA amplicon diagnostic for the respective CP4EPSPS polynucleotide is an aspect of the present invention. The amplification conditions for this analysis is illustrated in Table 27 and Table 28, however, any modification of these conditions including the use of fragments of the DNA molecules of the present invention or complements thereof as primer molecules, which produce an amplicon DNA molecule diagnostic for the artificial polynucleotides described herein is within the ordinary skill of the art. The DNA molecules of the present invention include at least SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:7, SEQ ID N0:10, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO: 17, SEQ ID NO:18, SEQ ID NO:2I, SEQ ID NO:22, and SEQ ID NO:35. DNA molecules that function as primer molecules in a DNA amplification method to detect the presence of the artificial polynucleotides include, but are not limited to SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ED N0:30, and SEQ EDNO:31. In a method for determining the presence of polynucleotides of the present invention, die analysis of plant tissue DNA extract sample should include a positive control known to contain the artificial polynucleotide, and a negative DNA extract control from a plant that is not transgenic or does not contain the artificial polynucleotide, and a negative control that contains no template in the DNA extract Additional DNA primer molecules of sufficient length can be selected from SEQ ID NO: 17 and SEQ ID NO: 18 and conditions optimized for the production of an amplicon that may differ from the methods shown in Table 27 and Table 28, but result in an amplicon diagnostic for the artificial polynucleotides. The use of these DNA primer sequences homologous or complementary to SEQ ID NO: 17 and SEQ ID NO: 18 used with or without modifications to the methods of Table 27 and 28 are within the scope of the invention. The assay for the CP4EPSPS_AT and CP4EPSPS_ZM amplicon can be performed by using a Stratagene Robocycler, MJ Engine, Perkin-EImer 9700, or Eppendorf Mastercycler Gradient thermocycler as shown in Table 28, or by methods and apparatus known to those skilled in the art. Table 27. DNA amplification procedure and reaction mixture for the confirmation of artificial EPSPS polynucleotide CP4EPSPS_A1 f in corn plants. Step Reagent Amount Comments 1 Nuclease-free water add to final volume of 20 pi - 2 10X reaction buffer (with MgCl2) 2.0 pi IX final concentration of buffer, 1.5 mM final concentration ofMgCh 3 10 mM solution of dATP, dCTP, dGTP, and dTTP 0.4 pi 200 pM final concentration of each dNTP 4 primer (SEQ ID NO:24) (resuspended in IX TE buffer or nuclease-free water to a concentration of 10 pM) 0.4 pi 0.2 pM final concentration 5 primer (SEQ ID NO:25) (resuspended in IX TE buffer or nuclease-free water to a concentration of 10 pM) 0.4 pi 0.2 pM final concentration 6 control primer (SEQ ID NO:32) (resuspended in IX TE buffer or nuclease-free water to a concentration of 10 pM) 0.2 pi 0.1 pM final concentration 7 control primer (SEQ ED NO:33) (resuspended in IX TE buffer or nuclease-free water to a concentration of 10 pM) 0.2 nl 0.1 pM final concentration 8 RNase, DNase free (500 ng/jxl) 0.1 nl 50 ng/reaction 9 REDTaq DNA polymerase (1 unit/jil) 1.0 pi (recommended to switch pipets prior to next step) 1 unit/reaction 10 Extracted DNA (template): • Samples to be analyzed * individual leaves * pooled leaves (maximum of 50 leaves/pool) • Negative control • Negative control • Positive control • 10-200 ng of genomic DNA • 200 ng of genomic DNA • 50 ng of nontransgenic plant genomic DNA • no template DNA • 5 ng plasmid DNA Table 28. Suggested PCR parameters for different thermocyclers Gently mix and, if needed (no hot top on thermocycler), add 1-2 drops of mineral oil on top of each reaction. Proceed with the PCR in a Stratagene Robocycler, MJ Engine, Perkin-Elmer 9700, or Eppendorf Mastercycler Gradient thermocycler using the following cycling parameters. Note: The MJ Engine or Eppendorf Mastercycler Gradient thermocycler should be run in the calculated mode. Run the Perkin-Elmer 9700 thermocycler with the ramp speed set at maximum. Cycle No. Settings: Stratagene Robocycler 1 94°C 3 minutes 38 94°C 1 minute 60°C 1 minute 72°C 1 minute and 30 seconds 1 72°C 10 minutes Cycle No. Settings: MJ Engine or Perkin-Elmer 9700 1 94°C 3 minutes 38 94°C 10 seconds 60°C 30 seconds 72°C 1 minute 1 72°C 10 minutes Cycle No. Settings: Eppendorf Mastercycler Gradient 1 94°C 3 minutes 38 94°C 15 seconds 60°C 15 seconds 72°C 1 minute 1 72°C 10 minutes All of the compositions and methods disclosed and claimed herein can be made and executed in light of the present disclosure. While the compositions and methods of this invention have been described, it will be apparent to those of skill in the art that variations may be applied to the compositions and methods and in the steps or in the sequence of steps of the methods described herein without departing from the concept, spirit and scope of the invention. More specifically, it will be apparent that certain agents which are both chemically and physiologically related may be substituted for the agents described herein while the same or similar results would be achieved. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims. All publications and patent applications cited herein are incorporated by reference in their entirely to the same extent as if each individual publication or patent application is specifically and individually indicated to be incorporated by reference. Claims: A method to reduce transgene silencing in transgenic plants comprising the steps of: a) constructing an artificial polynucleotide that is divergent from a known polynucleotide that encodes a substantially identical protein, and b) constructing a DNA construct containing said artificial polynucleotide molecule; and c) transforming said DNA construct into a plant cell; and d) regenerating said plant cell into a fertile transgenic plant, wherein said artificial polynucleotide and said known polynucleotide are divergent if less than 85 percent identical for their entire length and have no polynucleotide sequence lengths more than 23 nucleotides that have 100 percent identity.7 2. In the method of claim 1, wherein said known polynucleotide occurs naturally)in said fertile transgenic plant. 3. In the method of claim 1, wherein said known polynucleotide occurs as a transgene in said fertile transgenic plant. 4. In the method of claim 1, wherein said artificial polynucleotide is expressed in said fertile transgenic plant. In the method of claim 4, wherein said artificial polynucleotide provides an agronomically useful phenotype selected from the group consisting of: herbicide tolerance, msect resistance, drought tolerance, increased yield, cold tolerance, disease resistance. Jrf^ An artificial polynucleotide molecule that is divergent from a known polynucleotide that encodes a substantially identicapprotein, said artificial polynucleotide molecule is selected from the group consisting of: SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO: 10, SEQ ID NO:13, SEQ ID NO:l4, SEQ ID NO:17, SEQ ID NO:f8, SEQ ID NO:2l SEQ ID NO:22^and SEQ ID NO:35; ' 'wherein said artificial polynucleotide and said known polynucleotide are divergent if less than 85 percent identical for their entire length and have no polynucleotide sequence lengths more than 23 nucleotides that have 100 percent identity^,/ Q A DNA construct comprising: a promoter 9iolecule_, that functions in plants, operably linked to said artificial polynucleotide molecule of claim 6. 8. A plant cell, plant or progeny thereof comprising the DNA construct of claim 7. 9. The plant or progeny thereof of claim 8, wherein said plant is selected from the group consisting of wheat, corn, rice, soybean, cotton, potato, canola, turf grass, forest trees, grain sorghum, vegetable crops, ornamental plants, forage crops, and fruit crops. 10. A plant cell comprising at least two polynucleotides, wherein said two polynucleotides encode a substantially identical protein and at least one of the polynucleotides is a transgene, and said polynucleotides are less than 85 percent identical in polynucleotide sequence for their entire length and have no polynucleotide sequence lengths more than 23 nucleotides that have 100 percent identity j 11. A plant or progeny of said plant cell of claim 10 comprising said two polynucleotides. ' 12. A plant or progeny thereof of claim 11, wherein said two polynucleotides encode for a herbicide tolerance protein. 13. A plant or progeny thereof of claim 12 comprising said herbicide tolerance protein, wherein said herbicide tolerance protein is selected from the group consisting of glyphosate resistant EPSPS and phosphinothricin acetyl transferase. 14. A plant cell, plant or progeny thereof comprising an artificial polynucleotide molecule of claim 6.^ ^YS. A method of detecting an artificial polynucleotide in said plant cell, plant or progeny thereof of claim 14 comprising the steps: (a) contacting a DNA sample isolated from said plant cell, plant or progeny thereof with a DNA molecule, wherein said DNA molecule comprises at least one DNA molecule of a pair of DNA molecules (hat when used in a nucleic-acid amplification reaction produces an amplicon that is diagnostic for said artificial polynucleotide molecule of claim 6; ^ (b) performing a nucleic acid amplification reaction, thereby producing the amplicon; and (c) detecting the amplicon 16. A DNA molecule comprising: a polynucleotide molecule that specifically hybridizes to an artificial polynucleotide molecule of claim 6. 17. A DNA molecule selected from the group consisting of: SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, and SEQ ID NO:27. 18. A plant cell, plant or progeny thereof, comprising a DNA molecule selected from the group consisting of: SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, and SEQ ID NO:27. 19. Apair of DNA molecules comprising a first DNA molecule and a second DNA molecule, wherein the first DNA molecule is SEQ ID NO:24 or its complement and the second DNA molecule is SEQ ID NO:25 or its complement and the pair of DNA molecules when used in a DNA amplification method produces an amplicon diagnostic for an artificial polynucleotide of SEQ ID NO: 17 20. A plant cell, plant or progeny thereof, wherein said amplicon of claim 19 is produced from genomic DNA extracted from said plant cell, plant or progeny thereof. 21. A pair of DNA molecules comprising a first DNA molecule and a second DNA molecule, wherein the first DNA molecule is SEQ ID NO:26 or its complement and the second DNA molecule is SEQ ID NO:27 or its complement and the pair of DNA molecules when used in a DNA amplification method produces an amplicon diagnostic for an artificial polynucleotide of SEQ ID NO: 18 22. A plant cell, plant or progeny thereof, wherein said amplicon of claim 21 is produced from genomic DNA extracted from said plant cell, plant or progeny thereof. A DNA detection kit comprising at least one DNA molecule of sufficient length to be specifically homologous or complementary to an artificial polynucleotide of claim 6 wherein said DNA molecule is useful as a DNA probe or DNA primer. 24. A DNA detection kit comprising at least one DNA molecule homologous or complementary to a DNA molecule selected from the group consisting of: SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, and SEQ ID NO:27. ^J^^j K method of detecting the presence of an artificial polynucleotide encoding a glyphosate resistant EPSPS in a DNA sample, the method comprising: (a) extracting a DNA sample from a plant; and (? (b) contacting the DNA sample with a labeled DNA molecule of sufficient length to be specifically homologous or complementary to an artificial polynucleotide selected from the group consisting of: SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, /% SEQ ID NO: 10, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:17, SEQ ID NO:18, and _^SEQ ID NO:35Tyherein said artificial polynucleotide is divergent from a known polynucleotide that encodes a substantially identical glyphosate resistant EPSPS protein, wherein said artificial polynucleotide and said known polynucleotide are divergent if less than 85 percent identical for their entire length and have no polynucleotide sequence lengths more than 23 nucleotides that have 100 percent identity and wherein said labeled DNA molecule is a DNA probe; and (c)subjecting the sample and DNA probe to stringent hybridization conditions; and (d) detecting the DNA probe hybridized to the DNA sample. An isolated polynucleotide that encodes an EPSPS enzyme, wherein said EPSPS enzyme comprises motif SEQ ED NO:34. 27. A plant cell, plant or progeny thereof tolerant to glyphosate comprising an EPSPS enzyme with motif SEQ ED NO:34

Documents:

214-CHENP-2005 CORRESPONDENCE OTHERS 05-05-2011.pdf

214-CHENP-2005 AMENDED CLAIMS 01-02-2012.pdf

214-CHENP-2005 AMENDED CLAIMS 08-09-2011.pdf

214-CHENP-2005 AMENDED PAGES OF SPECIFICATION 08-09-2011.pdf

214-CHENP-2005 CORRESPONDENCE OTHERS 01-02-2012.pdf

214-CHENP-2005 FORM-1 08-09-2011.pdf

214-CHENP-2005 FORM-3 01-02-2012.pdf

214-CHENP-2005 FORM-3 08-09-2011.pdf

214-CHENP-2005 OTHER PATENT DOCUMENT 08-09-2011.pdf

214-CHENP-2005 OTHER PATENT DOCUMENT-1 08-09-2011.pdf

214-CHENP-2005 OTHER PATENT DOCUMENT-2 08-09-2011.pdf

214-CHENP-2005 POWER OF ATTORNEY 08-09-2011.pdf

214-chenp-2005 abstract.pdf

214-chenp-2005 claims.pdf

214-chenp-2005 correspondence others.pdf

214-chenp-2005 correspondence po.pdf

214-chenp-2005 description (complete).pdf

214-CHENP-2005 EXAMINATION REPORT REPLY RECEIVED 08-09-2011.pdf

214-chenp-2005 form-1.pdf

214-chenp-2005 form-18.pdf

214-chenp-2005 form-3.pdf

214-chenp-2005 form-5.pdf

214-chenp-2005 pct.pdf

214-CHENP-2005 SEQUENCE LISTING 08-09-2011.pdf

214-chenp-2005 sequence listing.pdf